Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3035400	s-afmaksa	u/l (u/l)	2148	2642	0.00%
3035400	s-afmaksa	— (—)	346	370	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of liver

474

742

6.54

288.17

1.3

1.2

121.35

81.84

u/l

6.95

429

636

ILD medications: immunosuppressive drugs

626

1170

5.04

283.06

1.3

1.2

93.05

88.65

u/l

0.22

556

1024

Dialysis, with operation codes

270

212

13.35

281.57

1.5

1.2

117.21

84.75

u/l

2.44

250

175

Chronic kidney disease

395

563

7.04

255.59

1.4

1.2

116.49

90.49

u/l

1.37

358

475

Renal failure

512

830

5.55

252.41

1.3

1.2

121.29

90.13

u/l

2.54

464

701

Nephropathy related operations

253

218

12.16

248.98

1.5

1.2

132.07

95.32

u/l

1.21

234

186

Care involving dialysis

188

125

15.89

215.80

1.5

1.2

102.87

99.10

u/l

0.09

174

104

All chronic kidney diseases

524

916

4.74

211.30

1.3

1.2

112.40

81.97

u/l

2.76

470

794

Autoimmune diseases excluding thyroid diseases

792

1170

3.72

203.44

1.3

1.2

102.34

86.85

u/l

2.33

703

1015

Autoimmune diseases excluding thyroid diseases, strict definition

764

1119

3.77

199.74

1.3

1.2

103.54

86.40

u/l

2.63

679

968

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

772

1536

3.50

197.76

1.3

1.2

111.80

84.36

u/l

3.59

697

1334

Renal tubulo-interstitial diseases

706

1471

3.61

194.00

1.3

1.2

117.36

80.94

u/l

5.26

637

1268

Transplanted organ and tissue status

183

149

12.80

186.48

1.4

1.1

137.46

85.42

u/l

1.27

170

129

Anaemias

228

113

13.37

185.66

1.3

1.2

121.39

74.56

u/l

1.75

209

ILD medications

786

1293

3.32

171.57

1.3

1.2

97.21

90.34

u/l

0.46

691

1139

All kidney diseases

728

1519

3.30

170.75

1.3

1.2

113.12

82.97

u/l

3.89

648

1326

L04AD Calcineurin inhibitors

194

197

10.24

170.50

1.4

1.1

124.91

86.06

u/l

0.97

178

171

First line medication for Crohn's disease

757

1222

3.37

168.91

1.3

1.2

99.90

89.66

u/l

0.75

666

1070

Bacterial infection, other or unspecified

502

1081

3.97

164.17

1.3

1.2

115.61

81.36

u/l

7.01

470

921

Other diseases of liver

254

377

6.92

162.85

1.3

1.2

118.50

77.91

u/l

3.73

233

329

Bacterial infection, other or unspecified

472

1027

4.04

158.99

1.3

1.2

117.80

81.33

u/l

7.25

443

874

ILD medications: prednisolone, methylprednisolone, prednisone

742

1286

3.25

158.81

1.4

1.2

99.07

90.68

u/l

0.57

653

1132

Other bacterial diseases

705

1485

3.22

158.00

1.4

1.2

118.12

80.51

u/l

5.42

640

1281

Autoimmune diseases related-to ILD

644

1718

3.23

156.20

1.3

1.2

92.04

91.08

u/l

0.07

570

1504

Preparatory care for dialysis

122

19.62

154.44

1.4

1.2

85.47

95.52

u/l

0.31

112

Fibrosis and cirrhosis of liver

157

138

11.94

152.63

1.4

1.1

142.67

74.07

u/l

5.81

144

121

Inflammatory bowel disease treatment related agents

773

1451

3.00

145.79

1.3

1.2

90.91

91.27

u/l

0.03

675

1283

ILD medications: azathioprine

185

223

8.49

142.17

1.3

1.1

92.30

86.47

u/l

0.19

162

193

L04AA Selective immunosuppressants

272

496

5.60

141.60

1.3

1.2

110.68

85.56

u/l

0.86

250

432

Other bacterial diseases

703

1493

3.01

138.94

1.3

1.2

117.64

79.10

u/l

5.56

638

1290

IBD patients in KELA-register

252

437

5.87

138.26

1.4

1.2

76.77

84.33

u/l

0.58

210

380

Heart failure, not strict

570

1172

3.33

135.45

1.3

1.2

108.22

82.34

u/l

4.73

517

1002

Dental caries

262

460

5.56

134.04

1.3

1.2

118.01

90.32

u/l

2.03

236

391

Azathioprine

185

241

7.85

133.26

1.3

1.1

92.30

84.60

u/l

0.27

162

210

Inflammatory bowel disease, strict (require KELA)

252

453

5.66

133.12

1.4

1.2

76.77

86.99

u/l

0.84

210

397

Tramadol

573

1079

3.29

129.15

1.3

1.2

97.78

86.16

u/l

1.46

497

939

Second line medication for Crohn's disease

465

1369

3.43

129.09

1.3

1.2

80.18

90.67

u/l

1.22

409

1194

Kidney transplant status

116

14.41

126.16

1.5

1.2

126.42

91.09

u/l

0.44

106

Bacterial Sepsis

396

885

3.87

125.50

1.4

1.2

123.31

81.43

u/l

6.00

357

762

Glomerular disorders in diseases classified elsewhere

168

211

8.21

125.06

1.5

1.2

105.22

96.63

u/l

0.37

162

178

Examination and observation for other reasons

459

705

3.80

124.23

1.2

90.43

86.24

u/l

0.35

422

612

Extracorporeal dialysis

122

100

12.81

124.03

1.6

1.2

111.12

92.16

u/l

0.52

113

5-aminosalicylic acid

221

376

5.98

123.68

1.4

1.2

79.90

82.11

u/l

0.11

184

330

Implicit bacterial Sepsis

353

778

4.07

121.25

1.3

1.2

124.92

84.03

u/l

4.89

318

661

Septicaemia

345

802

4.07

120.52

1.3

1.2

135.90

81.66

u/l

3.57

311

677

L04AX Other immunosuppressants

446

1345

3.35

119.23

1.2

80.05

91.19

u/l

1.29

393

1171

Mucosal proctocolitis

164

212

7.93

119.00

1.4

1.1

83.00

86.22

u/l

0.13

137

179

Inflammatory bowel disease

298

681

4.44

118.78

1.4

1.2

77.73

85.96

u/l

0.76

253

593

Noninfective enteritis and colitis

380

1043

3.68

117.29

1.4

1.2

86.60

87.26

u/l

0.04

328

900

Caries of dentine

227

406

5.53

115.88

1.3

1.2

113.48

87.95

u/l

1.65

204

343

Polyarthropathies

507

1024

3.26

115.23

1.2

1.3

91.36

98.19

u/l

0.67

447

900

Glomerular diseases

207

357

5.92

114.42

1.4

1.2

99.96

92.17

u/l

0.43

197

300

Autoimmune diseases

661

1180

2.86

111.93

1.3

1.2

94.87

86.79

u/l

0.83

585

1024

Explicit Sepsis

349

868

3.79

110.68

1.3

1.2

135.63

81.46

u/l

3.67

315

743

Implicit bacterial Sepsis

367

861

3.72

110.63

1.3

1.2

125.97

81.81

u/l

5.58

332

739

Other septicaemia

306

721

4.13

109.95

1.3

1.2

136.94

82.54

u/l

3.07

277

602

Ulcer of lower limb, not elsewhere classified

176

269

6.70

109.81

1.3

1.2

122.70

85.53

u/l

3.50

162

228

Persons encountering health services for specific procedures and health care

685

1537

2.69

109.22

1.3

1.2

100.32

88.13

u/l

1.32

620

1334

Budesonide

170

252

6.90

109.14

1.5

1.1

86.27

80.10

u/l

0.27

146

223

Acute renal failure

207

386

5.46

105.17

1.3

1.2

132.47

87.67

u/l

3.18

192

319

Abnormal findings on examination of blood, without diagnosis

361

951

3.52

102.18

1.3

1.2

117.81

93.18

u/l

2.46

322

816

Unspecified kidney failure

134

164

8.40

101.88

1.2

1.3

132.19

90.47

u/l

0.66

115

140

Implicit Sepsis

517

1357

2.89

100.82

1.3

1.2

116.16

81.77

u/l

5.55

463

1170

Used for control exclusion in common control thyroid runs

596

1063

2.85

99.78

1.3

1.2

93.41

91.40

u/l

0.11

528

920

Fever of other and unknown origin

386

1040

3.33

99.59

1.3

1.2

108.51

79.98

u/l

5.01

357

901

GASTRO-related operations

436

637

3.45

98.22

1.2

1.1

94.61

68.56

u/l

4.56

392

521

Any gastric operation

436

637

3.45

98.22

1.2

1.1

94.61

68.56

u/l

4.56

392

521

Ulcerative colitis

228

505

4.58

94.68

1.4

1.2

80.47

85.05

u/l

0.29

190

436

Disorders resulting from impaired renal tubular function

15.45

93.65

1.4

1.2

120.34

84.12

u/l

0.33

Reimbursement for rheumatic diseases

425

1439

2.97

92.79

1.3

1.2

98.71

86.07

u/l

1.19

382

1244

Cholangitis (primary sclerosing, PSC)

101

10.68

91.71

1.3

1.2

154.43

77.63

u/l

3.11

Implicit Sepsis

531

1437

2.72

91.65

1.3

1.2

114.33

80.89

u/l

5.54

474

1240

Osteopathies and chondropathies

418

1310

3.00

91.55

1.3

1.2

97.42

85.59

u/l

1.14

371

1129

Oral corticosteroids

620

1432

2.58

91.46

1.3

1.2

94.47

91.76

u/l

0.22

545

1266

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

183

351

5.31

90.20

1.4

1.2

78.31

90.05

u/l

0.85

151

303

Pneumonias (Asthma/COPD co-morbidities)

620

1661

2.52

90.18

1.3

1.2

112.27

82.05

u/l

6.26

559

1445

Aplastic and other anaemias

356

1027

3.26

89.90

1.3

1.2

123.96

87.26

u/l

2.28

321

879

All pneumoniae

622

1667

2.51

89.45

1.3

1.2

112.25

81.91

u/l

6.34

561

1451

Crohn disease

145

225

6.58

89.17

1.4

1.2

75.30

81.77

u/l

0.34

125

191

Dialysis

14.75

88.32

1.5

1.2

92.12

92.46

u/l

0.00

Ulcerative colitis (strict definition, require KELA)

174

326

5.43

88.05

1.4

1.2

78.35

89.90

u/l

0.78

143

280

Influenza and pneumonia

637

1647

2.47

87.80

1.3

1.2

109.31

81.76

u/l

5.61

574

1433

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

170

313

5.53

87.70

1.4

1.2

78.74

90.09

u/l

0.73

140

269

Any reimbursement code in KELA

278

311

4.50

87.27

1.2

1.1

90.62

80.29

u/l

0.69

245

273

Other anaemias

333

965

3.31

86.64

1.3

1.2

123.59

87.70

u/l

2.00

300

826

Heart failure,strict

355

758

3.33

85.76

1.2

117.73

80.37

u/l

6.67

316

640

Insulin, fast-acting

275

755

3.68

85.16

1.3

1.2

119.77

84.96

u/l

4.16

249

648

Other and unspecified anaemias

328

955

3.31

85.11

1.3

1.2

124.00

88.03

u/l

1.96

295

819

Metabolic disorders

591

1429

2.54

84.96

1.3

1.2

94.87

88.20

u/l

0.68

522

1248

563

1322

2.59

84.27

1.3

1.2

109.31

80.70

u/l

5.99

506

1148

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

563

1322

2.59

84.27

1.3

1.2

109.31

80.70

u/l

5.99

506

1148

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

159

292

5.56

82.35

1.3

1.2

152.03

87.22

u/l

4.32

146

244

Nonalcoholic fatty liver disease

132

206

6.59

80.92

1.2

1.1

102.76

82.58

u/l

0.67

118

177

Diabetic nephropathy, excluding more controls

167

251

5.60

80.91

1.4

1.2

111.31

102.42

u/l

0.35

158

216

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

593

1673

2.43

80.41

1.3

1.2

112.27

82.67

u/l

5.74

535

1455

Insulin, intermediate and long-acting

371

1230

2.95

80.11

1.3

1.2

115.57

87.88

u/l

3.84

336

1061

Other Crohn's disease

102

9.58

80.09

1.3

1.1

74.88

73.11

u/l

0.06

Secondary hypertension

108

9.18

79.69

1.3

1.1

85.37

87.93

u/l

0.06

Condition for Implicit Sepsis (Organ dysfunction codes)

537

1474

2.53

79.15

1.3

1.2

113.39

79.96

u/l

5.64

483

1281

Insulin, fast-acting or short human

277

803

3.48

79.04

1.3

1.2

119.60

87.94

u/l

3.47

251

686

Disorders of parathyroid gland

210

496

4.25

78.93

1.3

1.2

70.66

85.73

u/l

1.80

184

424

Pneumonia, organism unspecified

548

1563

2.47

77.56

1.3

1.2

113.37

82.62

u/l

5.58

494

1355

Condition for Implicit Sepsis (Organ dysfunction codes)

521

1468

2.52

76.88

1.3

1.2

114.10

80.51

u/l

5.46

467

1271

Nutritional anaemias

357

1187

2.92

75.52

1.3

1.2

116.36

86.83

u/l

1.64

323

1025

Abnormal serum enzyme levels

225

568

3.91

75.42

1.3

119.96

98.23

u/l

1.67

198

477

Diabetic nephropathy

169

349

4.88

75.20

1.4

1.2

112.85

104.31

u/l

0.37

160

301

Insulin, combination of fast acting with intermediate-acting or long-acting

402

1347

2.75

74.91

1.3

1.2

121.99

88.60

u/l

4.56

364

1166

Malaise and fatigue

341

903

3.06

74.85

1.2

100.61

80.38

u/l

3.11

297

784

Type 1 diabetes

200

482

4.19

74.37

1.3

1.2

122.17

82.83

u/l

3.59

184

412

Hyperparathyroidism

187

433

4.34

72.28

1.3

1.2

67.62

85.63

u/l

2.46

164

371

Insulin medication

402

1251

2.72

72.24

1.3

1.2

121.99

86.63

u/l

5.03

364

1087

Certain infectious and parasitic diseases

532

1064

2.52

70.91

1.3

1.2

92.66

78.85

u/l

2.10

464

918

Implicit viral Sepsis

218

580

3.80

70.84

1.3

1.2

112.04

82.78

u/l

3.34

199

487

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

566

1579

2.35

70.33

1.3

1.2

105.80

85.56

u/l

1.55

509

1372

Iron deficiency anaemia

307

1013

3.01

68.90

1.3

1.2

122.75

85.45

u/l

1.90

279

873

Other and unspecified iron deficiency

251

751

3.37

68.24

1.3

1.2

122.39

85.19

u/l

1.46

228

641

Other disorders of kidney and ureter

137

261

5.36

68.22

1.3

1.2

101.92

89.25

u/l

0.17

125

220

Ulcerative colitis, NAS

135

254

5.41

68.09

1.2

1.1

77.66

82.71

u/l

0.27

111

214

Crohn's disease NAS

8.92

67.87

1.4

1.1

73.87

71.74

u/l

0.08

Heart failure, strict

377

962

2.79

67.57

1.2

119.23

86.17

u/l

5.56

333

829

Disorders of gallbladder, biliary tract and pancreas

581

1614

2.28

67.27

1.3

1.2

111.51

84.99

u/l

4.86

517

1404

Type 1 diabetes, wide definition, subgroup 1

164

368

4.51

67.00

1.3

1.2

122.20

77.54

u/l

3.92

155

317

General symptoms and signs

577

1236

2.35

66.80

1.3

1.2

101.66

78.90

u/l

3.77

506

1082

Acute tubulo-interstitial nephritis

373

1220

2.65

64.36

1.3

1.2

120.78

79.76

u/l

2.79

333

1048

Heart failure and antihypertensive medication

192

294

4.32

64.31

1.2

128.03

93.43

u/l

2.28

175

251

Erysipelas

415

1250

2.55

64.14

1.3

1.2

110.26

80.88

u/l

4.37

360

1068

Disorders of other endocrine glands

310

1069

2.88

64.08

1.3

1.2

91.04

88.93

u/l

0.05

275

924

Diseases of oesophagus, stomach and duodenum

594

1609

2.22

63.58

1.3

1.2

92.71

90.36

u/l

0.19

518

1418

All-cause Heart Failure

364

952

2.72

62.48

1.2

117.94

85.81

u/l

5.22

321

820

Erysipelas

336

1090

2.75

62.26

1.3

1.2

110.13

83.44

u/l

3.26

294

928

Ulcerative colitis (strict definition, all Crohn cases excluded)

129

259

5.06

60.48

1.3

1.2

76.53

89.61

u/l

0.73

106

221

Hypertensive diseases (excluding secondary)

301

572

3.08

60.46

1.3

1.2

92.94

83.19

u/l

0.62

267

500

Type 1 diabetes, wide definition

165

404

4.12

60.20

1.3

1.2

122.35

81.95

u/l

3.28

156

349

Other heart diseases

274

577

3.12

58.56

1.3

1.2

111.24

88.15

u/l

1.18

251

502

Opioids

511

1149

2.32

58.33

1.3

1.2

94.34

85.12

u/l

0.94

445

1006

Infections, IBD-co-morbidities

118

142

6.00

58.25

1.3

111.50

101.01

u/l

0.29

103

129

Implicit viral Sepsis

154

370

4.21

57.78

1.3

1.2

109.62

80.71

u/l

2.60

143

312

Viral Sepsis

154

370

4.21

57.78

1.3

1.2

109.62

80.71

u/l

2.60

143

312

Gout, FINNGEN

194

548

3.57

57.56

1.3

109.13

101.99

u/l

0.35

168

468

Other disorders of skin and subcutaneous tissue

429

1635

2.35

57.41

1.3

1.2

106.71

87.52

u/l

2.27

375

1430

Hypertension, essential

422

967

2.48

57.08

1.3

1.2

92.20

87.75

u/l

0.32

376

845

Exposure to unspecified factor

555

1875

2.14

57.04

1.3

1.2

87.42

94.13

u/l

0.72

480

1658

Persons encountering health services for other counselling and medical advice, not elsewhere classified

613

1585

2.11

56.76

1.3

1.2

95.59

88.07

u/l

0.76

550

1384

Insulin, fast-acting (human)

117

231

5.13

55.92

1.4

1.1

127.30

87.59

u/l

2.14

108

193

Sub-endpoint used in defining T1D endpoints

201

584

3.42

55.69

1.3

1.2

119.43

94.37

u/l

1.69

186

498

Other inflammatory liver diseases

112

7.42

55.60

1.2

1.1

105.71

76.10

u/l

1.51

Hypertension

424

986

2.44

55.26

1.3

1.2

96.84

88.64

u/l

0.58

378

864

Hypertensive diseases

423

986

2.43

54.89

1.3

1.2

96.95

88.64

u/l

0.59

377

864

Gout

194

489

3.53

54.73

1.3

109.13

106.32

u/l

0.11

168

414

Other diseases of intestines

551

1460

2.15

54.45

1.3

1.2

98.29

87.74

u/l

1.04

480

1285

Intestinal infectious diseases

522

1862

2.14

54.15

1.3

1.2

99.20

88.97

u/l

1.13

465

1629

Gastrointestinal diseases

273

439

3.13

53.59

1.2

94.79

68.87

u/l

3.24

242

376

Diseases of arteries, arterioles and capillaries (FINNGEN)

172

301

3.99

53.52

1.3

1.2

99.28

82.65

u/l

1.10

152

255

Codeine

474

1130

2.29

53.29

1.2

84.83

85.76

u/l

0.07

411

989

Oedema, not elsewhere classified

215

679

3.15

52.33

1.3

1.2

99.09

78.50

u/l

2.07

188

586

Complications of surgical and medical care, not elsewhere classified

547

1804

2.09

52.14

1.3

1.2

99.26

89.50

u/l

1.22

485

1583

Diseases of arteries, arterioles and capillaries

400

1261

2.36

52.03

1.3

1.2

107.74

88.87

u/l

2.31

356

1092

Diarrhoea and gastroenteritis of presumed infectious origin

394

1539

2.32

51.59

1.3

1.2

110.56

87.86

u/l

1.17

351

1337

Pain in limb

446

1327

2.26

51.48

1.2

92.05

94.15

u/l

0.16

390

1168

Intestinal infectious diseases

613

1743

2.02

51.18

1.3

1.2

94.46

89.44

u/l

0.54

545

1528

Crohn's disease of large intestine

8.48

50.67

1.3

1.1

78.68

67.79

u/l

0.40

Other arthritis (FG)

209

675

3.12

50.32

1.2

1.3

88.33

87.06

u/l

0.07

190

578

Malignant neoplasm of breast, HER2-negative

300

730

2.71

50.24

1.2

68.44

79.59

u/l

1.47

277

643

Heart failure and bmi 25plus

220

465

3.22

50.04

1.2

119.21

81.33

u/l

4.45

189

404

Finngen Rheumatological endpoints

498

1313

2.17

49.91

1.2

86.86

93.72

u/l

0.74

443

1158

Cardiovascular diseases (excluding rheumatic etc)

312

672

2.68

49.45

1.3

1.2

94.06

87.24

u/l

0.30

282

587

Other disorders of fluid, electrolyte and acid-base balance

212

660

3.09

49.42

1.3

102.98

85.24

u/l

1.55

189

560

Malignant neoplasm of breast

299

735

2.68

48.81

1.2

68.81

80.07

u/l

1.49

276

648

Chronic hepatitis, not elsewhere classified

10.38

48.03

1.4

1.1

105.08

74.31

u/l

0.76

Osteoporosis

209

646

3.06

47.64

1.3

1.2

102.65

82.11

u/l

1.35

180

563

Malignant neoplasm of breast, HER2-negative, including Hilmo

300

742

2.64

47.62

1.2

68.99

79.89

u/l

1.43

278

653

Malignant neoplasm of breast, including Hilmo

300

742

2.64

47.61

1.2

68.99

79.89

u/l

1.43

278

653

Crohn's disease of small intestine

110

6.87

47.55

1.6

1.1

72.85

73.46

u/l

0.02

Bleeding

465

1562

2.13

47.12

1.3

1.2

108.28

87.64

u/l

2.95

411

1354

Crohn disease (strict definition, require KELA, min 2 HDR)

103

7.05

46.68

1.3

1.2

65.21

81.65

u/l

0.78

Adjustment and management of implanted device

132

332

4.02

46.66

1.2

115.35

94.43

u/l

1.30

120

286

Crohn disease (strict definition, require KELA)

105

6.92

45.86

1.3

1.2

65.21

81.59

u/l

0.79

Malignant neoplasm

445

1213

2.18

45.83

1.3

1.2

100.75

88.53

u/l

0.57

404

1054

Persons encountering health services for specific procedures, not carried out

121

6.39

45.70

1.3

1.1

91.57

89.53

u/l

0.05

104

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

118

6.50

45.68

1.3

1.2

63.59

78.94

u/l

0.79

105

Diseases of the digestive system

281

1115

2.52

45.36

1.3

1.2

112.72

89.65

u/l

2.65

258

959

Care involving use of rehabilitation procedures

349

1402

2.30

45.23

1.2

90.45

88.86

u/l

0.08

307

1211

Pain in joint

311

790

2.52

45.16

1.2

80.26

90.15

u/l

1.04

272

689

Gout, idiopatic and unspecified

164

491

3.38

44.83

1.3

109.19

101.82

u/l

0.33

145

412

Endocrine, nutritional and metabolic diseases

376

807

2.37

44.77

1.3

1.2

86.62

83.11

u/l

0.23

338

699

Malignant neoplasm of breast, HER-positive

236

659

2.82

44.58

1.2

69.99

79.61

u/l

0.98

217

578

Unspecified privation

188

5.08

44.40

1.2

111.42

83.44

u/l

1.17

161

Malignant neoplasm of breast, ER-positive, including Hilmo

238

662

2.80

44.26

1.2

69.75

79.60

u/l

1.03

219

581

Medical observation and evaluation for suspected diseases and conditions

340

708

2.47

44.19

1.3

1.2

93.49

86.06

u/l

0.48

296

615

Other specified/unspecified arthritis

185

602

3.10

44.06

1.2

1.3

82.73

90.85

u/l

0.67

169

519

Amputation

186

5.09

43.91

1.4

1.2

138.55

92.70

u/l

2.17

160

Gout, strict definition

129

334

3.91

43.85

1.2

1.3

106.26

99.09

u/l

0.28

114

276

Disorders of lipoprotein metabolism and other lipidaemias

445

1300

2.13

43.80

1.2

91.12

89.25

u/l

0.13

394

1130

Complications of procedures, not elsewhere classified

439

1759

2.07

43.12

1.3

1.2

99.47

89.83

u/l

1.03

388

1540

Malignant neoplasm, wide definition for exclusion

446

1240

2.12

42.73

1.3

1.2

101.41

88.24

u/l

0.63

404

1078

Other and unspecified polyneuropathies, also in other diseases

139

386

3.64

42.71

1.3

1.2

104.66

88.45

u/l

0.93

123

326

Peripheral artery disease

261

804

2.60

42.70

1.3

115.11

91.05

u/l

2.43

237

685

Other heart diseases, wide

465

1379

2.07

42.48

1.3

1.2

103.97

86.80

u/l

1.64

418

1209

Covid-19 confirmed case

225

833

2.72

42.33

1.4

1.2

108.23

86.97

u/l

2.02

207

712

Persons encountering health services in other circumstances, wide

591

1589

1.92

42.10

1.2

99.61

88.01

u/l

1.35

523

1388

Asthma, unspecified (mode), excluding more controls

266

778

2.57

41.93

1.3

1.2

88.69

73.04

u/l

1.95

235

670

Biological medication for rheuma

131

356

3.72

41.57

1.2

73.97

88.74

u/l

1.21

118

308

Certain infectious and parasitic diseases

350

745

2.36

41.35

1.3

1.2

96.38

78.63

u/l

1.92

302

646

Gout, unspecified

138

390

3.58

41.31

1.3

106.89

101.29

u/l

0.22

124

322

Codeine or tramadol medication

570

1630

1.92

41.19

1.2

84.87

94.09

u/l

1.30

492

1435

Pain, not elsewhere classified

173

565

3.09

40.96

1.3

1.2

94.35

76.16

u/l

1.54

157

488

Asthma, excluding more controls

358

812

2.31

40.73

1.3

1.2

95.16

72.23

u/l

3.69

318

700

Polyneuropathies and other disorders of the peripheral nervous system

151

458

3.33

40.50

1.2

102.82

88.94

u/l

0.83

134

380

Complications of medical and surgical care

406

1812

2.07

40.47

1.3

1.2

105.55

88.57

u/l

2.18

362

1582

Sulfasalazine

178

596

3.01

40.38

1.3

1.2

79.01

84.76

u/l

0.34

161

517

Peripheral artery operations in Hilmo

101

232

4.41

40.31

1.4

1.2

125.58

91.82

u/l

1.57

199

Any event in cancer register

453

1306

2.05

40.03

1.3

1.2

98.57

88.37

u/l

0.48

407

1139

Oxycodone

221

749

2.69

39.74

1.5

1.2

111.85

87.04

u/l

1.91

207

646

Ascites

140

5.54

39.42

1.3

1.2

164.36

85.02

u/l

3.33

122

Solid cancers, helper endpoint

424

1204

2.09

39.30

1.3

1.2

94.85

88.63

u/l

0.25

383

1046

Other diseases of intestine

112

285

3.98

39.06

1.3

1.2

109.07

81.34

u/l

0.97

244

Certain disorders involving the immune mechanism

142

426

3.37

38.80

1.3

1.2

102.69

89.07

u/l

0.54

132

366

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

345

1589

2.15

38.69

1.3

1.2

102.36

89.18

u/l

1.34

305

1382

Diabetes, varying definitions

519

1585

1.93

38.60

1.3

1.2

104.92

84.12

u/l

3.15

465

1387

Infections of the skin and subcutaneous tissue

310

1379

2.24

38.26

1.3

1.2

100.46

92.35

u/l

0.54

277

1197

Cardiovascular diseases

263

550

2.58

38.10

1.2

93.58

87.80

u/l

0.20

235

479

Codes for special purposes

287

1250

2.30

38.05

1.3

1.2

104.44

87.68

u/l

1.76

265

1080

Other soft tissue disorders, not elsewhere classified

461

1357

2.00

38.02

1.2

90.19

94.50

u/l

0.38

402

1195

Diarrhoea and gastroenteritis of presumed infectious origin

508

1762

1.91

37.70

1.3

1.2

95.00

90.01

u/l

0.41

453

1543

Atherosclerosis, excluding cerebral and coronary sclerosis

238

742

2.56

37.62

1.3

110.01

92.06

u/l

1.60

216

633

Tumor necrosis factor alpha inhibitors

116

313

3.75

37.25

1.2

69.73

88.59

u/l

1.93

104

273

Hypertensive heart and/or renal disease

154

354

3.27

37.21

1.2

1.3

121.40

88.34

u/l

2.50

144

304

Provisional assignment of new diseases of uncertain etiology

285

1251

2.29

37.11

1.3

1.2

104.32

87.73

u/l

1.72

263

1081

Chronic gastritis

179

633

2.85

36.86

1.2

99.52

88.09

u/l

0.70

153

547

Diabetes mellitus

515

1589

1.90

36.84

1.3

1.2

104.98

84.19

u/l

3.12

461

1391

Heart failure and coronary heart disease

252

721

2.49

36.79

1.2

126.14

89.55

u/l

4.46

226

614

Low back pain

386

1346

2.07

36.61

1.3

1.2

91.41

91.82

u/l

0.03

346

1184

Disorders of mineral metabolism

146

5.23

36.60

1.4

1.1

96.75

92.90

u/l

0.09

122

Bacterial pneumoniae

224

781

2.54

35.98

1.3

1.2

127.71

85.59

u/l

1.54

206

667

Bacterial pneumonia, not elsewhere classified

216

743

2.58

35.59

1.3

1.2

112.21

86.37

u/l

2.79

198

632

Other noninfective gastroenteritis and colitis

158

534

2.98

35.29

1.3

1.2

99.65

87.26

u/l

0.59

138

457

Acute peritonitis

108

5.95

35.28

1.3

1.1

93.40

78.88

u/l

0.56

GI-bleeding

190

710

2.70

35.20

1.2

109.05

93.86

u/l

1.14

173

599

Asthma

369

909

2.14

35.19

1.3

1.2

95.06

75.80

u/l

2.88

327

785

Asthma (only as main-diagnosis), excluding more controls

318

812

2.25

35.10

1.3

1.2

94.24

72.23

u/l

2.99

288

700

Asthma, unspecified (mode)

269

869

2.34

34.97

1.3

1.2

88.77

76.18

u/l

1.42

237

750

Rheumatoid arthritis

203

698

2.63

34.93

1.2

1.3

82.79

92.83

u/l

0.88

182

608

COPD/asthma/ILD related infections

502

1322

1.91

34.92

1.3

1.2

93.37

80.70

u/l

1.89

448

1148

COPD/asthma related infections

502

1322

1.91

34.92

1.3

1.2

93.37

80.70

u/l

1.89

448

1148

Hernia of abdominal wall, postoperative

252

3.96

34.50

1.3

1.1

97.30

63.58

u/l

2.71

204

Continuous positive airway pressure

120

285

3.58

34.42

1.2

1.3

116.91

72.91

u/l

3.45

112

243

Glomerulonephritis

178

4.62

34.29

1.3

1.2

86.32

95.38

u/l

0.30

149

Neoplasms

321

764

2.23

34.22

1.2

101.65

88.30

u/l

0.42

279

672

Cholelithiasis, broad definition with cholecystitis

439

1534

1.93

34.14

1.2

97.95

83.81

u/l

1.93

389

1332

Other specific joint derangements/joint disorders

350

1078

2.11

34.07

1.2

1.3

80.91

95.16

u/l

1.95

305

951

Follow-up examination after treatment for conditions other than malignant neoplasms

235

626

2.50

33.95

1.3

1.2

87.63

83.55

u/l

0.26

207

542

Liquid cancers, helper endpoint

209

717

2.56

33.92

1.2

134.29

85.67

u/l

1.57

192

620

Diseases of the skin and subcutaneous tissue

474

1241

1.92

33.74

1.3

1.2

95.61

86.54

u/l

0.76

410

1090

Pure hypercholesterolaemia

380

1226

2.03

33.71

1.2

95.25

89.53

u/l

0.44

336

1061

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

478

1538

1.88

33.33

1.3

1.2

111.50

85.09

u/l

3.88

427

1344

Other diseases of the digestive system

188

719

2.63

33.30

1.2

109.20

94.42

u/l

1.08

172

604

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

221

548

2.56

33.13

1.3

1.2

103.58

81.98

u/l

2.25

196

477

Cutaneous abscess, furuncle and carbuncle

158

554

2.87

33.11

1.3

1.2

101.37

83.90

u/l

1.04

143

478

Explicit bacterial Sepsis

168

4.64

32.85

1.5

1.2

110.86

79.98

u/l

1.18

144

Streptococcal septicaemia

130

5.23

32.82

1.5

1.1

118.42

82.94

u/l

1.14

108

Hypothyroidism (congenital or acquired)

117

4.61

32.66

1.2

89.94

74.59

u/l

0.71

Spondyloarthritis

111

318

3.52

32.62

1.2

123.87

90.35

u/l

1.37

103

271

Medicines for HER+ breast cancer

242

994

2.33

32.42

1.2

69.99

83.68

u/l

1.77

222

869

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

312

1509

2.08

31.95

1.3

1.2

104.67

89.53

u/l

1.46

275

1310

Diabetes medication

508

1662

1.82

31.90

1.3

1.2

108.69

83.96

u/l

3.87

452

1455

Other retinal disorders

343

1318

2.04

31.89

1.3

1.2

97.71

92.23

u/l

0.42

294

1163

Cholelithiasis

420

1525

1.91

31.52

1.2

97.82

83.62

u/l

1.88

371

1326

Abnormalities of breathing

418

1262

1.93

31.36

1.3

1.2

105.75

87.20

u/l

2.09

370

1102

Viral pneumonia

221

4.03

31.33

1.4

1.2

106.20

83.75

u/l

1.12

188

Fracture of femur

165

547

2.76

31.30

1.3

1.2

99.56

90.14

u/l

0.37

146

462

Haemorrhage from respiratory passages

197

709

2.52

31.29

1.2

106.12

86.52

u/l

1.70

173

608

L02BG Aromatase inhibitors

211

878

2.42

31.27

1.2

63.75

84.44

u/l

4.32

193

766

Diabetes, insulin treatment (Kela reimbursement)

504

1689

1.81

31.25

1.3

1.2

110.04

85.41

u/l

3.72

448

1476

Asthma (mode)

353

918

2.07

31.23

1.3

1.2

94.98

75.98

u/l

2.84

312

793

Pleural effusion

107

309

3.50

31.13

1.2

115.32

89.91

u/l

1.21

263

Alcoholic liver disease

168

4.53

31.03

1.2

1.1

145.77

83.35

u/l

2.38

141

Adalimumab

164

4.57

31.02

1.1

68.42

92.41

u/l

1.74

141

Atrial fibrillation and flutter

173

403

2.80

31.02

1.3

1.2

105.37

84.20

u/l

1.03

161

345

Non-ischemic cardiomyopathy

182

558

2.64

31.01

1.2

1.3

104.83

85.93

u/l

1.42

161

478

Lower back pain or/and sciatica

507

1868

1.78

30.26

1.3

1.2

91.89

90.36

u/l

0.12

447

1640

Ulcerative rectosigmoiditis

125

5.11

30.12

1.4

1.1

87.87

75.87

u/l

0.46

105

Fall on same level

533

1649

1.77

30.10

1.3

1.2

99.01

89.74

u/l

0.78

455

1468

Type 2 diabetes, wide definition

410

1387

1.90

30.01

1.2

102.77

85.27

u/l

2.29

362

1205

Hypothyroidism, levothyroxine purchases

117

4.41

29.89

1.2

89.60

74.59

u/l

0.66

Hypothyroidism and >3 levothyroxin purchases

117

4.41

29.89

1.2

89.60

74.59

u/l

0.66

Cardiac arrhythmias

283

851

2.17

29.80

1.3

1.2

101.05

77.91

u/l

1.80

257

748

252

3.73

29.76

1.3

1.2

85.99

78.70

u/l

0.32

218

Systemic connective tissue disorders

213

915

2.34

29.49

1.3

1.2

87.01

84.91

u/l

0.14

189

792

Disorders of choroid and retina

414

1581

1.87

29.49

1.3

1.2

95.34

92.01

u/l

0.26

354

1393

Asthma (only as main-diagnosis)

324

909

2.07

29.46

1.3

1.2

94.17

75.80

u/l

2.28

292

785

Bacterial pneumonia (organism specified)

237

959

2.25

29.40

1.3

1.2

125.77

90.44

u/l

1.29

219

819

Diaphragmatic hernia

222

973

2.30

29.34

1.2

84.87

87.06

u/l

0.10

184

848

Crohn disease (strict definition, all UC cases excluded)

6.22

29.31

1.3

1.1

65.25

75.30

u/l

0.33

Dyspnoea

444

1812

1.82

29.20

1.2

106.61

87.93

u/l

2.35

393

1585

Personal history of malignant neoplasm

137

4.83

29.02

1.2

1.1

64.43

72.68

u/l

0.37

120

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

344

1592

1.94

28.77

1.2

103.33

89.64

u/l

1.48

302

1378

Nausea and vomiting

160

596

2.65

28.64

1.3

1.2

128.77

85.36

u/l

1.75

145

506

Congenital malformations of the urinary system

5.68

28.37

1.4

1.2

167.57

83.50

u/l

0.53

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

100

4.93

28.07

1.1

1.3

89.56

87.04

u/l

0.07

Other ulcerative colitis

5.83

28.07

1.4

1.1

100.49

76.33

u/l

0.93

Viral pneumonia (unknown virus, not influenza)

107

5.32

27.96

1.3

1.2

120.06

84.09

u/l

1.36

Other diseases of urinary system

472

1486

1.79

27.96

1.2

96.36

89.78

u/l

0.54

413

1308

Other diseases of blood and blood-forming organs, wide

144

528

2.75

27.86

1.2

138.15

85.25

u/l

1.13

132

453

Other CVD (FINNGEN)

127

4.50

27.69

1.4

1.3

88.15

85.27

u/l

0.07

109

Statin medication

323

899

2.03

27.63

1.2

101.97

90.82

u/l

0.76

277

803

Seropositive rheumatoid arthritis

156

597

2.62

27.49

1.2

79.90

85.61

u/l

0.42

143

517

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

140

4.64

27.32

1.4

1.2

124.37

80.40

u/l

1.44

120

Benign neoplasm of colon, rectum, anus and anal canal

332

1499

1.93

27.23

1.2

98.72

90.12

u/l

0.68

285

1308

Paralytic ileus and intestinal obstruction

149

563

2.66

27.13

1.4

1.2

109.83

85.12

u/l

1.63

133

481

Type 2 diabetes

466

1538

1.78

27.11

1.2

100.22

84.90

u/l

2.28

416

1344

Artificial opening status

5.73

26.98

1.3

1.2

158.05

84.09

u/l

1.30

Asthma, hospital admissions 3, pneumonia

205

899

2.29

26.94

1.3

1.2

103.80

89.58

u/l

1.14

182

770

Asthma-related pneumonia or sepsis

205

899

2.29

26.94

1.3

1.2

103.80

89.58

u/l

1.14

182

770

Excluding asthma or asthma-COPD overlap

358

920

1.96

26.92

1.3

1.2

94.14

75.47

u/l

2.90

320

796

Congenital malformations of the urinary system

104

5.28

26.75

1.4

1.2

166.02

81.16

u/l

0.55

Asthma-related pneumonia

204

898

2.28

26.58

1.3

1.2

104.00

89.64

u/l

1.15

181

769

COPD differential diagnosis

356

918

1.95

26.52

1.2

95.76

75.98

u/l

3.05

319

793

ILD differential diagnosis

356

918

1.95

26.52

1.2

95.76

75.98

u/l

3.05

319

793

Rheumatoid arthritis, including avohilmo

222

1017

2.20

26.42

1.2

83.52

86.89

u/l

0.24

197

880

Constipation

439

1720

1.77

26.34

1.3

1.2

93.04

90.73

u/l

0.17

392

1499

Polycystic kidney disease

7.91

26.06

1.3

1.1

85.16

75.80

u/l

0.35

Asthma-related infections

295

1476

1.96

26.03

1.3

1.2

100.51

92.83

u/l

0.51

264

1285

Asthma, hospital admission 2, infections

295

1476

1.96

26.03

1.3

1.2

100.51

92.83

u/l

0.51

264

1285

Pain in throat and chest

382

1238

1.86

25.94

1.2

94.17

86.62

u/l

0.67

340

1079

Speech therapy

163

660

2.49

25.82

1.2

88.80

86.55

u/l

0.08

136

567

Other pulmonary diagnosis

354

920

1.93

25.82

1.3

1.2

96.20

75.47

u/l

3.16

315

796

UC patients in KELA-register (code 208), prior to 1994

5.96

25.79

1.6

1.2

69.10

82.74

u/l

0.78

Diabetic retinopathy, excluding more controls

158

330

2.71

25.48

1.4

1.2

106.94

97.40

u/l

0.44

141

287

Other nutritional deficiencies

316

1565

1.91

25.42

1.3

1.2

83.84

87.56

u/l

0.33

280

1363

Disorders of thyroid, IBD co-morbidities

164

3.75

25.39

1.1

1.4

79.80

101.03

u/l

0.85

150

Diseases of peritoneum

206

3.79

25.20

1.3

1.2

94.29

82.88

u/l

0.45

174

Antihypertensive medication - note that there are other indications

240

577

2.21

25.20

1.2

1.3

94.42

84.47

u/l

0.49

215

504

Other systemic involvement of connective tissue (FG)

151

588

2.55

25.19

1.2

86.68

87.76

u/l

0.05

132

506

Chronic pancreatitis

234

3.59

25.14

1.3

1.2

136.15

82.09

u/l

2.82

200

Disorder of lipoprotein metabolism, unspecified

239

3.55

25.08

1.3

1.2

94.08

90.68

u/l

0.10

201

Benign neoplasm: Colon

286

1399

1.96

24.99

1.2

96.80

91.94

u/l

0.31

244

1221

Other bacterial intestinal infections

110

371

2.99

24.87

1.3

1.2

110.78

87.47

u/l

1.29

318

Gastro-oesophageal reflux disease

322

1474

1.89

24.87

1.3

1.2

86.37

90.54

u/l

0.30

276

1296

Cystitis

407

1350

1.80

24.85

1.2

87.75

88.85

u/l

0.08

353

1187

Spondylopathies

382

1255

1.82

24.48

1.2

91.50

93.91

u/l

0.14

331

1100

Depression

447

1760

1.73

24.44

1.2

99.61

85.61

u/l

1.50

395

1538

Diverticular disease of intestine

347

1189

1.87

24.37

1.2

86.22

89.76

u/l

0.24

300

1038

All influenza

130

486

2.69

24.24

1.4

1.2

98.56

85.93

u/l

0.76

122

411

Cystic kidney disease

6.43

24.10

1.3

1.2

190.18

79.42

u/l

0.51

Injuries to the hip and thigh

247

1101

2.04

23.96

1.3

1.2

99.09

88.96

u/l

0.59

216

950

Cystic kidney disease

6.31

23.73

1.3

1.2

190.18

79.55

u/l

0.51

Collagenous colitis

170

3.99

23.64

1.3

1.1

107.82

80.41

u/l

1.14

146

Abdominal and pelvic pain

441

1272

1.75

23.50

1.2

99.21

87.78

u/l

0.89

392

1104

Dorsalgia

446

1383

1.73

23.47

1.2

87.49

91.44

u/l

0.33

392

1220

Symptoms and signs involving the digestive system and abdomen

441

1272

1.74

23.29

1.2

102.38

87.78

u/l

1.19

390

1104

Vitreous haemorrhage

200

3.70

23.12

1.4

1.2

112.20

86.67

u/l

1.22

169

Other or unspecified ileus, impaction or obstruction

106

366

2.92

22.99

1.5

1.2

113.85

89.17

u/l

1.26

307

Symptoms and signs involving cognition, perception, emotional state and behaviour

450

1818

1.69

22.97

1.2

90.53

92.30

u/l

0.14

387

1611

Other functional intestinal disorders

223

998

2.08

22.97

1.3

1.2

103.38

86.04

u/l

1.52

205

869

Other diseases of pancreas

152

4.14

22.94

1.3

1.2

108.44

77.69

u/l

1.31

135

Mood disorders

474

1839

1.67

22.92

1.2

98.41

87.19

u/l

1.15

421

1611

Peripheral arterial reconstruction

101

341

2.99

22.84

1.3

104.06

96.84

u/l

0.27

286

Implicit fungal Sepsis

116

4.64

22.66

1.5

1.1

113.04

72.99

u/l

2.23

103

Mood [affective] disorders

472

1838

1.67

22.66

1.2

98.20

87.21

u/l

1.11

419

1611

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

143

265

2.72

22.56

1.1

93.55

64.26

u/l

2.27

125

224

Total colectomy operation

5.81

22.48

1.7

1.1

85.94

76.05

u/l

0.28

Total colectomy

5.81

22.48

1.7

1.1

85.94

76.05

u/l

0.28

Headache

278

1156

1.93

22.46

1.3

1.2

85.92

78.21

u/l

0.66

248

1011

Other gastritis (incl. Duodenitis)

127

489

2.62

22.41

1.3

1.2

107.38

89.84

u/l

0.91

112

418

Other diseases of pleura

225

960

2.06

22.41

1.3

1.2

129.05

92.49

u/l

3.06

204

821

Injuries to the abdomen, lower back, lumbar spine and pelvis

200

930

2.14

22.32

1.3

1.2

92.36

90.20

u/l

0.08

179

791

Atrial fibrillation and flutter with reimbursement

135

323

2.67

22.28

1.2

89.98

82.05

u/l

0.48

122

277

Arthropathies

389

1110

1.78

22.21

1.2

1.3

82.68

97.32

u/l

2.00

345

980

Cellulitis

123

469

2.64

22.14

1.4

1.2

105.42

81.31

u/l

1.63

113

404

Fracture of lumbar spine and pelvis

126

486

2.61

22.08

1.3

1.2

92.48

92.78

u/l

0.01

113

412

Other bacterial intestinal infections

128

500

2.58

21.94

1.3

1.2

112.28

88.03

u/l

1.44

110

431

Ulcerative proctitis

5.07

21.87

1.6

1.1

65.05

74.46

u/l

0.48

Bacterial intestinal infections, IBD co-morbidities

111

405

2.76

21.79

1.3

1.2

111.58

90.51

u/l

1.12

344

Hypertensive Heart Disease

116

329

2.78

21.78

1.2

1.3

125.19

89.83

u/l

2.06

108

284

Dermatitis and eczema

503

1921

1.63

21.74

1.3

1.2

90.67

91.23

u/l

0.04

439

1695

Hypokalaemia

223

3.44

21.71

1.3

1.2

94.36

88.38

u/l

0.21

190

Cardiomyopathy

298

3.08

21.71

1.2

1.3

114.04

89.19

u/l

1.23

254

Iron deficiency anaemia secondary to blood loss (chronic)

330

2.97

21.67

1.3

1.2

113.76

82.05

u/l

1.46

288

Cerebrovascular diseases (FINNGEN)

149

429

2.47

21.65

1.3

1.2

117.20

84.36

u/l

1.49

129

370

Noninfectious colitis NAS

258

3.25

21.63

1.3

1.1

94.63

78.44

u/l

0.56

217

Cholecystectomy

352

1732

1.76

21.57

1.2

89.98

91.01

u/l

0.07

309

1513

Nephrotic syndrome

6.41

21.08

1.3

1.2

84.40

87.33

u/l

0.06

Valvular heart disease excluding rheumatic fever

220

774

2.06

21.03

1.3

1.2

114.38

82.20

u/l

2.72

193

669

Other disorders of urethra and urinary system

327

1316

1.80

20.97

1.3

1.2

93.15

89.16

u/l

0.23

287

1154

Primary_lymphoid and hematopoietic malignant neoplasms

132

536

2.48

20.89

1.2

149.45

93.79

u/l

1.03

124

452

Non-rheumatic valve diseases

218

768

2.06

20.73

1.3

1.2

107.91

82.25

u/l

2.83

191

664

Parasetamol

310

843

1.87

20.66

1.2

95.16

89.59

u/l

0.32

268

749

215

1062

2.02

20.61

1.3

1.2

98.54

91.41

u/l

0.37

197

916

L02BA Anti-estrogens

116

446

2.63

20.61

1.2

74.41

79.05

u/l

0.22

108

391

Mood disorders, excluding more controls

432

1551

1.67

20.39

1.2

1.3

99.39

86.34

u/l

1.39

381

1371

L04AC Interleukin inhibitors

4.86

20.37

1.2

1.1

80.45

87.10

u/l

0.17

Use of hypnotics and sedatives

476

1682

1.63

20.37

1.3

1.2

94.76

91.27

u/l

0.26

406

1491

Asthma (diagnoses ohter than nonallergic)

397

1971

1.68

20.33

1.3

1.2

89.79

90.21

u/l

0.03

348

1734

Other diseases of arteries and capillaries

180

3.66

20.31

1.4

1.1

121.85

80.29

u/l

1.26

156

Gastroduodenal ulcer

131

537

2.45

20.18

1.2

111.36

96.73

u/l

0.58

116

462

Intestinal stricture

167

765

2.20

20.03

1.3

1.2

105.53

90.81

u/l

0.84

146

647

Other systemic involvement of connective tissue

156

696

2.26

19.97

1.2

86.47

85.37

u/l

0.05

137

601

Anxiety (asthma-related co-morbidities)

272

1130

1.87

19.96

1.2

1.3

91.11

84.07

u/l

0.37

236

987

Idiopathic gout

155

3.85

19.89

1.3

1.2

114.81

94.47

u/l

0.56

131

Diseases of the musculoskeletal system and connective tissue

210

497

2.12

19.86

1.2

1.3

92.35

102.57

u/l

0.44

176

444

Other CVD

108

408

2.67

19.85

1.4

1.2

83.77

95.33

u/l

0.59

343

Hyperlipidaemia, other/unspecified

186

816

2.11

19.85

1.2

99.28

89.35

u/l

0.51

161

703

Viral and other specified intestinal infections

122

470

2.52

19.84

1.3

1.2

147.12

79.78

u/l

1.30

113

406

Obesity

286

1528

1.81

19.80

1.2

1.3

80.07

88.77

u/l

1.09

254

1334

Symptoms and signs involving the circulatory and respiratory systems

424

1268

1.68

19.78

1.2

97.99

86.94

u/l

1.00

377

1107

Obesity and other hyperalimentation

287

1533

1.81

19.78

1.2

1.3

80.10

88.74

u/l

1.08

255

1338

Other infectious diseases

148

3.90

19.55

1.2

1.1

110.09

89.10

u/l

0.67

126

Diabetic retinopathy, strict definition

111

374

2.65

19.52

1.4

1.2

116.12

109.23

u/l

0.25

104

328

Pain (limb, back, neck, head abdominally)

301

817

1.85

19.47

1.2

91.66

97.63

u/l

0.30

260

714

Enterocolitis due to Clostridium difficile

205

3.40

19.38

1.3

1.2

114.73

91.75

u/l

0.79

173

Disorders of lens

334

1190

1.76

19.28

1.3

1.2

102.66

88.75

u/l

1.14

304

1028

Coagulation defects, purpura and other haemorrhagic conditions

110

426

2.60

19.27

1.3

1.2

121.24

89.16

u/l

1.20

103

369

Gingival hyperplasia

5.66

19.21

1.4

1.2

116.90

69.51

u/l

1.36

508

1657

1.59

19.19

1.3

1.2

94.44

86.52

u/l

0.86

458

1448

Benign neoplasms

410

1361

1.66

18.96

1.2

82.32

94.44

u/l

1.83

350

1205

Psoriatic and enteropathic arthropathies

208

3.35

18.94

1.2

69.03

89.21

u/l

1.60

181

Diabetic maculopathy, excluding more controls

184

3.51

18.91

1.4

1.2

118.07

89.62

u/l

1.12

154

Obesity, other/unspecified

169

796

2.13

18.91

1.2

79.75

85.61

u/l

0.52

157

693

Other infectious diseases

170

3.63

18.90

1.2

1.1

107.30

88.97

u/l

0.60

145

Depression medications

126

3.36

18.78

1.1

1.2

96.87

70.44

u/l

1.25

108

Benign neoplasm of other and ill-defined parts of digestive system

109

428

2.57

18.60

1.3

1.2

93.09

87.57

u/l

0.28

102

368

Gingivitis and periodontal diseases

447

1423

1.62

18.56

1.3

1.2

98.51

95.59

u/l

0.11

395

1231

Methotrexate

283

2.96

18.54

1.1

74.63

81.55

u/l

0.41

248

Viral and other specified intestinal infections

315

2.80

18.22

1.4

1.2

158.39

79.49

u/l

1.09

271

Periodontitis

438

1832

1.60

18.21

1.3

1.2

88.88

90.94

u/l

0.17

390

1600

Seropositive rheumatoid arthritis, wide

156

724

2.17

18.18

1.2

79.90

85.29

u/l

0.40

143

630

Syncope and collapse

193

823

2.01

18.08

1.3

1.2

111.56

81.16

u/l

2.55

165

714

Other/unspecified seropositive rheumatoid arthritis

154

714

2.17

18.00

1.2

80.59

84.39

u/l

0.26

141

620

Abnormal results of function studies

157

3.67

17.99

1.3

1.1

116.59

77.84

u/l

1.90

135

Bronchitis

474

1903

1.57

17.97

1.3

1.2

101.85

87.10

u/l

1.54

423

1668

Primary hyperparathyroidism

262

3.01

17.94

1.2

70.12

81.17

u/l

0.65

232

Acute pancreatitis

103

401

2.59

17.88

1.2

128.43

82.39

u/l

2.71

344

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

151

701

2.17

17.61

1.2

80.60

83.02

u/l

0.15

138

608

Hypo-osmolality and hyponatraemia

362

2.66

17.56

1.2

104.94

90.92

u/l

0.60

302

Diseases of the eye and adnexa

335

971

1.73

17.55

1.3

1.2

84.93

93.15

u/l

0.75

297

853

Anxiety disorders, excluding more controls

367

1444

1.66

17.38

1.2

1.3

89.59

83.48

u/l

0.45

321

1269

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

431

1737

1.59

17.35

1.3

1.2

98.26

91.67

u/l

0.66

379

1520

Cardiodefibrillation

171

835

2.05

17.34

1.2

1.3

108.25

94.81

u/l

0.58

151

718

Other disorders of glucose regulation and pancreatic internal secretion

138

3.81

17.31

1.4

1.1

116.93

92.47

u/l

0.83

120

All anxiety disorders

272

1212

1.78

17.21

1.2

91.11

85.82

u/l

0.26

236

1063

Chronic periodontitis, including avohilmo

433

1837

1.58

17.17

1.3

1.2

88.88

90.92

u/l

0.17

385

1605

Cough

197

960

1.95

17.12

1.2

103.45

85.57

u/l

0.38

177

832

Benzodiazepine use

442

1939

1.57

17.11

1.2

94.97

90.43

u/l

0.37

383

1712

Enlarged lymph nodes

307

2.79

17.11

1.3

1.2

130.53

78.00

u/l

1.95

265

Other disorders of white blood cells

4.52

17.07

1.1

1.2

126.17

79.75

u/l

1.35

Diabetic retinopathy

188

577

2.04

17.06

1.3

1.2

106.98

106.04

u/l

0.04

166

511

Other respiratory diseases principally affecting the interstitium

376

2.60

17.02

1.1

1.2

102.35

92.72

u/l

0.41

315

Hypothyroidism, strict autoimmune

265

968

1.80

17.00

1.2

85.27

86.14

u/l

0.06

239

828

Other external causes of accidental injury

346

1022

1.70

16.98

1.3

1.2

93.76

90.05

u/l

0.19

303

908

Other antidepressants

441

1425

1.59

16.78

1.2

1.3

91.46

92.29

u/l

0.05

377

1259

Other medical care

204

960

1.92

16.78

1.5

1.2

124.92

88.10

u/l

3.75

191

830

Accidents

344

1022

1.69

16.55

1.2

94.35

90.05

u/l

0.23

299

908

Other diseases of stomach and duodenum

125

3.89

16.45

1.3

1.1

107.30

79.31

u/l

0.89

108

Presence of cardiac and vascular implants and grafts

202

779

1.93

16.45

1.2

120.82

90.45

u/l

3.14

180

658

Paroxysmal tachycardia

100

330

2.55

16.29

1.5

1.2

100.96

83.77

u/l

0.81

284

Hypotension

338

2.65

16.28

1.4

1.2

89.93

96.88

u/l

0.26

287

Chronic periodontitis, complicated

255

1439

1.76

16.26

1.4

1.2

95.03

92.70

u/l

0.14

224

1249

Dermatitis

278

1620

1.72

16.13

1.3

1.2

94.35

90.71

u/l

0.24

234

1417

Other acute lower respiratory infections

233

1232

1.81

16.11

1.3

1.2

104.57

90.25

u/l

0.96

207

1067

Abnormalities of gait and mobility

257

2.91

16.07

1.2

119.57

85.04

u/l

0.81

224

Symptoms and signs concerning food and fluid intake

174

3.36

16.06

1.3

1.1

167.12

81.08

u/l

0.65

148

Other/unspecified dorsalgia

178

901

1.97

16.04

1.2

85.88

89.37

u/l

0.18

150

775

Irritable bowel syndrome

133

613

2.18

15.83

1.2

91.68

80.73

u/l

0.49

118

535

Invasive ventilation

129

3.77

15.74

1.2

205.16

92.95

u/l

0.71

113

Neurotic, stress-related and somatoform disorders

388

1714

1.59

15.73

1.2

91.69

87.26

u/l

0.29

340

1504

Other and unspecified dermatitis

236

1328

1.78

15.72

1.2

93.88

90.81

u/l

0.19

203

1152

Chronic tubulo-interstitial nephritis

4.94

15.71

1.3

1.2

75.43

69.56

u/l

0.24

Anxiety disorders

392

1730

1.58

15.68

1.2

91.04

87.31

u/l

0.24

344

1518

Volume depletion

154

3.47

15.48

1.3

1.2

141.79

97.05

u/l

0.94

127

Depression or dysthymia

302

979

1.71

15.46

1.2

1.3

101.02

89.68

u/l

0.75

264

862

Vitamin B12 deficiency anaemia

189

3.20

15.42

1.3

1.2

89.96

85.58

u/l

0.15

164

Chronic apical periodontitis

476

1785

1.52

15.41

1.2

94.38

89.68

u/l

0.39

409

1575

Acute bronchitis

188

973

1.90

15.34

1.3

1.2

106.69

89.00

u/l

1.07

169

839

Falls/tendency to fall

445

1439

1.55

15.29

1.3

1.2

97.28

88.93

u/l

0.66

385

1273

Malignant neoplasm of breast, HER-negative

113

485

2.30

15.25

1.3

1.2

64.23

76.96

u/l

1.20

102

425

Soft tissue disorders

419

1377

1.57

15.24

1.3

1.2

85.94

93.98

u/l

0.83

366

1214

Sequelae of external causes of morbidity and mortality

135

637

2.13

15.17

1.3

1.2

85.19

88.93

u/l

0.18

118

547

Complications of internal orthopaedic prosthetic devices, implants and grafts

118

528

2.25

15.14

1.3

1.2

101.27

88.44

u/l

0.56

101

443

Open wound of lower leg

306

2.67

15.02

1.4

1.2

129.15

93.73

u/l

0.91

265

AV-block

264

2.70

15.02

1.2

111.63

93.74

u/l

0.88

228

Other dorsopathies, not elsewhere classified

414

1387

1.57

14.94

1.2

89.50

91.30

u/l

0.12

363

1223

Hypoglycaemia, other or unspecified

111

3.92

14.93

1.4

1.1

123.86

89.93

u/l

1.11

Diagnoses used for exclusion with ILD

129

602

2.15

14.92

1.2

100.68

92.92

u/l

0.49

114

513

Diabetic neuropathy

267

2.79

14.86

1.3

117.78

105.03

u/l

0.35

233

Persons encountering health services for examination and investigation

252

708

1.79

14.82

1.2

94.21

86.06

u/l

0.51

218

615

Other cataract

217

909

1.81

14.61

1.3

1.2

100.87

86.18

u/l

0.91

193

779

Fracture of rib(s), sternum and thoracic spine

139

674

2.07

14.55

1.3

1.2

93.20

95.38

u/l

0.09

119

571

Acute pancreatitis (for exclusion)

103

443

2.34

14.52

1.2

128.43

87.69

u/l

2.20

376

Elevated blood glucose level

132

3.60

14.48

1.1

1.2

95.17

85.10

u/l

0.30

114

Other anxiety disorders

197

927

1.85

14.45

1.2

84.70

83.26

u/l

0.07

169

819

Malignant neoplasm of breast, ER-negative, including Hilmo

120

524

2.20

14.41

1.3

1.2

65.55

79.00

u/l

1.34

108

459

Operations 2 for CAVS

135

629

2.09

14.39

1.3

1.2

109.70

95.43

u/l

1.01

123

532

Calcific aortic valvular stenosis, diagnosis (helper)

135

629

2.09

14.39

1.3

1.2

109.70

95.43

u/l

1.01

123

532

Calcific aortic valvular stenosis

135

630

2.09

14.34

1.3

1.2

109.70

95.27

u/l

1.02

123

533

Calcific aortic valvular stenosis, operated

135

630

2.09

14.34

1.3

1.2

109.70

95.27

u/l

1.02

123

533

Mycoses

131

626

2.10

14.27

1.4

1.2

103.84

86.17

u/l

1.19

119

533

Any death

288

1242

1.67

14.27

1.4

1.2

134.05

81.45

u/l

7.81

265

1064

Calcific aortic valvular stenosis, including rheumatic fever

135

631

2.08

14.24

1.3

1.2

109.70

95.82

u/l

0.97

123

534

Viral infections characterized by skin and mucous membrane lesions

367

2019

1.56

14.24

1.2

85.79

91.96

u/l

0.63

326

1772

Injuries to the thorax

199

1097

1.82

14.23

1.2

90.25

93.85

u/l

0.23

176

946

Other joint disorders

340

1109

1.62

14.21

1.2

1.3

76.38

97.28

u/l

4.56

298

979

Hard cardiovascular diseases

370

1403

1.58

14.19

1.3

1.2

107.29

88.68

u/l

1.51

332

1223

Colectomy operation

376

2.44

14.06

1.4

1.2

111.91

92.50

u/l

0.66

325

All influenza (not pneumonia)

244

2.80

13.94

1.4

1.1

93.40

89.85

u/l

0.10

207

Exposure to other specified factors

315

1812

1.60

13.87

1.3

1.2

85.54

90.27

u/l

0.39

276

1586

Fracture of lower leg, including ankle

251

1475

1.69

13.86

1.2

92.25

89.10

u/l

0.18

229

1274

Mycoses

361

2031

1.55

13.74

1.3

1.2

86.72

90.27

u/l

0.34

320

1784

Sarcoidosis

286

2.64

13.71

1.2

1.1

98.50

86.89

u/l

0.61

246

Conduction disorders

127

487

2.12

13.66

1.2

105.10

85.14

u/l

1.50

115

416

Genitourinary diseases

211

577

1.84

13.58

1.2

107.88

90.20

u/l

0.83

182

500

Need for other prophylactic measures

101

3.91

13.52

1.1

1.2

82.41

82.26

u/l

0.00

Sciatica+with lumbago

223

1187

1.73

13.40

1.3

1.2

91.02

90.00

u/l

0.05

193

1038

Persons with potential health hazards related to communicable diseases

152

777

1.95

13.39

1.3

1.2

109.30

91.71

u/l

0.58

138

689

Hernia

405

1795

1.52

13.37

1.3

1.2

92.38

90.50

u/l

0.11

349

1582

Symptoms and signs involving the skin and subcutaneous tissue

307

1893

1.59

13.36

1.2

85.27

90.95

u/l

0.56

277

1650

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

165

877

1.89

13.33

1.2

80.95

85.70

u/l

0.26

146

758

Senile cataract

291

1090

1.64

13.23

1.3

1.2

99.33

89.12

u/l

0.76

267

940

Overexertion and strenuous or repetitive movements

192

3.00

13.14

1.3

1.1

95.94

84.20

u/l

0.33

163

Osteoporosis with pathological fracture (FG)

146

3.33

13.13

1.2

1.1

123.72

78.05

u/l

1.27

128

Acute upper respiratory infections of multiple and unspecified sites

312

1456

1.59

13.05

1.3

1.2

101.00

87.73

u/l

0.90

282

1258

Seropositive rheumatoid arthritis, strict definition

359

2.41

13.03

1.2

72.08

86.70

u/l

1.27

315

Diseases of the respiratory system

268

797

1.69

13.01

1.2

93.83

76.34

u/l

2.16

243

689

Recurrent or chronic depression

179

678

1.86

13.00

1.2

1.3

96.70

84.59

u/l

0.50

157

599

Valvular operations

232

2.78

12.91

1.4

1.3

163.95

91.19

u/l

1.89

200

Abnormal weight loss

168

3.12

12.89

1.3

1.2

97.80

81.65

u/l

0.85

147

Myocardial infarction, without ST-elevation

177

884

1.83

12.79

1.2

1.3

114.88

94.76

u/l

1.29

156

752

STROKE

237

947

1.71

12.78

1.3

1.2

106.95

80.25

u/l

1.92

205

818

Factors influencing health status and contact with health services

111

244

2.29

12.72

1.1

99.46

76.33

u/l

1.21

209

Myocardial infarction

218

884

1.74

12.69

1.3

1.2

107.48

88.49

u/l

1.50

189

762

Amiodarone users

202

2.90

12.63

1.1

1.3

106.79

92.19

u/l

0.58

173

Other pleural conditions

197

2.92

12.58

1.3

1.2

144.56

96.10

u/l

1.57

168

Trigger finger

347

2.41

12.55

1.3

1.2

86.83

86.54

u/l

0.01

307

Sequelae with surgical and medical care as external cause

104

479

2.18

12.53

1.3

1.2

84.20

89.37

u/l

0.23

413

Other reaction to severe stress, and adjustment disorders

156

832

1.88

12.49

1.3

1.2

95.86

81.24

u/l

0.61

141

733

Gastric ulcer

348

2.40

12.46

1.2

119.91

92.74

u/l

0.86

298

Dorsopathies

411

1393

1.50

12.37

1.2

85.18

91.00

u/l

0.50

364

1229

Cardiomyopathies, Primary/intrinsic

194

2.91

12.30

1.2

131.54

91.39

u/l

1.58

163

Cardiomyopathy (excluding other)

205

2.85

12.28

1.2

129.84

88.74

u/l

1.72

170

Papulosquamous disorders

181

1017

1.79

12.27

1.2

95.34

86.45

u/l

0.56

163

872

Asthma, hospital admissions , main diagnosis only

345

2003

1.52

12.24

1.3

1.2

92.39

91.70

u/l

0.04

308

1756

Psoriasis

138

713

1.94

12.19

1.2

95.13

88.37

u/l

0.31

123

612

Seronegative rheumatoid arthritis

223

2.76

12.15

1.1

85.32

84.62

u/l

0.02

193

Injuries to the knee and lower leg

492

1902

1.44

12.13

1.3

1.2

94.10

90.01

u/l

0.32

436

1669

Other special examinations and investigations of persons without complaint or reported diagnosis

238

708

1.71

12.05

1.3

1.2

101.78

86.06

u/l

0.93

210

615

Asthma, including avohilmo

485

1896

1.44

12.03

1.3

1.2

93.77

93.40

u/l

0.02

428

1669

Chronic lower respiratory diseases

492

1826

1.44

11.99

1.3

1.2

102.30

90.66

u/l

1.02

433

1609

Other (not insulin) diabetes medications

400

1597

1.49

11.93

1.2

101.47

84.86

u/l

2.14

354

1394

Benign neoplasm: Colon, unspecified

122

610

2.01

11.86

1.2

107.30

92.04

u/l

0.64

103

523

Injuries to unspecified part of trunk, limb or body region

182

2.93

11.85

1.3

1.2

113.07

78.67

u/l

1.13

162

Personality disorders, excluding more controls

107

511

2.10

11.75

1.1

1.2

94.81

78.08

u/l

0.85

454

Injuries to the head

455

1941

1.44

11.70

1.2

100.92

90.90

u/l

0.89

381

1727

Alcohol use disorder, Swedish definition

217

1190

1.68

11.61

1.2

1.3

116.77

95.59

u/l

1.36

181

1051

Other arrhythmias

253

1180

1.62

11.52

1.2

96.37

82.95

u/l

0.96

222

1027

Dizziness and giddiness

318

1648

1.53

11.49

1.2

90.96

91.21

u/l

0.01

271

1456

Intestinal malabsorption

3.89

11.39

1.4

1.2

156.67

76.05

u/l

2.10

Cyst of kidney

134

3.24

11.36

1.3

1.1

65.21

90.08

u/l

1.96

117

Abnormal findings on diagnostic imaging of lung

213

1227

1.67

11.30

1.2

97.80

89.40

u/l

0.54

187

1067

Emergency coronary revascularization (for ACS)

368

1504

1.49

11.14

1.3

1.2

102.91

91.46

u/l

0.90

327

1311

227

1255

1.64

11.13

1.2

1.3

114.69

94.90

u/l

1.32

191

1110

Lichen simplex chronicus and prurigo

116

3.40

11.10

1.3

1.1

87.84

85.09

u/l

0.08

Unspecified haematuria

174

819

1.77

11.08

1.2

114.27

93.97

u/l

1.33

153

702

Retention of urine

134

575

1.92

11.08

1.3

1.2

109.66

94.50

u/l

0.88

120

494

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

104

499

2.07

10.95

1.8

1.2

108.25

90.23

u/l

0.73

428

ILD, hospital admissions

320

2.36

10.90

1.1

1.2

94.38

88.42

u/l

0.24

272

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

309

2.36

10.90

1.4

1.2

115.23

89.43

u/l

0.58

268

Symptoms and signs involving the urinary system

319

1609

1.51

10.84

1.3

1.2

94.85

91.13

u/l

0.23

278

1401

Percutaneous Coronary Intervention

343

1404

1.50

10.76

1.2

104.21

90.37

u/l

1.10

307

1227

Non-allergic asthma (mode), excluding more controls

343

2.29

10.75

1.2

106.82

66.48

u/l

1.74

296

Early onset COPD, excluding more controls

378

2.23

10.75

1.1

1.2

113.36

74.74

u/l

1.95

321

Weight loss

193

2.77

10.69

1.3

1.1

97.60

80.39

u/l

0.99

168

Tubulo-interstitial nephritis, not specified as acute or chronic

109

3.42

10.68

1.2

111.75

71.71

u/l

1.82

Other interstitial pulmonary diseases

323

2.34

10.68

1.1

1.2

94.38

93.12

u/l

0.04

275

Spondylosis

230

1159

1.62

10.67

1.2

85.28

94.00

u/l

0.68

196

1009

Obesity due to excess calories

189

1121

1.69

10.64

1.2

1.3

78.79

85.88

u/l

0.62

166

976

Other (seronegative) rheumatoid arthritis, wide

100

486

2.07

10.57

1.2

92.48

85.13

u/l

0.33

417

Conjunctivitis

313

1739

1.51

10.56

1.2

76.15

86.97

u/l

1.39

281

1520

Congenital malformations, deformations and chromosomal abnormalities

231

1373

1.61

10.55

1.3

1.2

86.90

87.26

u/l

0.02

201

1205

Ischemic heart diseases

356

1444

1.48

10.54

1.2

101.99

90.47

u/l

0.89

316

1262

Disorders of continuity of bone

189

2.77

10.53

1.2

1.1

77.83

83.74

u/l

0.27

167

Any mental disorder

448

1574

1.43

10.48

1.2

101.13

89.58

u/l

0.89

388

1392

Interstitial lung disease endpoints

326

2.32

10.47

1.1

1.2

94.38

93.54

u/l

0.03

278

Interstitial lung disease

326

2.32

10.47

1.1

1.2

94.38

93.54

u/l

0.03

278

Congenital malformations, deformations and chromosomal abnormalities

254

1496

1.57

10.44

1.3

1.2

86.28

87.47

u/l

0.07

221

1309

Chronic rhinitis, nasopharyngitis and pharyngitis

148

824

1.80

10.43

1.3

1.2

81.50

89.22

u/l

0.45

127

710

Disorders of synovium and tendon

216

1162

1.63

10.42

1.2

1.3

79.49

89.99

u/l

1.25

194

1019

Chronic ulcer of skin, not elsewhere classified

126

3.21

10.41

1.3

1.2

104.31

84.80

u/l

0.51

106

External causes of morbidity and mortality

259

812

1.60

10.39

1.2

92.80

90.45

u/l

0.09

224

721

Type 2 diabetes, strict (exclude DM1)

378

1522

1.46

10.33

1.2

96.17

85.13

u/l

1.29

332

1326

Fracture of shoulder and upper arm

164

943

1.74

10.31

1.2

97.27

86.85

u/l

0.60

141

817

Diseases of pulp and periapical tissues, including avohilmo

423

1529

1.44

10.28

1.2

91.25

92.17

u/l

0.06

361

1348

Major coronary heart disease event excluding revascularizations

259

1099

1.57

10.27

1.2

102.08

88.31

u/l

1.17

226

945

Non-selective monoamine reuptake inhibitors

172

967

1.72

10.26

1.1

1.3

91.50

88.78

u/l

0.12

151

840

Exclusions for E4_PCOS_BROAD

354

2.24

10.24

1.3

1.2

86.27

94.30

u/l

0.33

305

Persistent mood disorders

440

2.10

10.16

1.1

1.2

87.91

83.78

u/l

0.15

379

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

339

2.24

10.09

1.4

1.2

113.61

88.14

u/l

0.61

296

Abnormal findings on diagnostic imaging of other body structures

307

2.33

10.05

1.2

109.13

82.32

u/l

1.15

270

233

1296

1.59

10.04

1.2

1.3

113.12

95.02

u/l

1.19

196

1145

Coronary revascularization (ANGIO or CABG)

339

1404

1.48

10.03

1.2

102.93

90.37

u/l

0.96

303

1227

Type 2 diabetes, definitions combined

373

1507

1.46

10.03

1.2

95.08

85.16

u/l

1.11

328

1314

Neurological diseases, wide definition

195

2.27

10.02

1.1

1.3

77.09

124.32

u/l

1.30

179

Disorders of conjunctiva

337

1846

1.47

10.00

1.2

77.40

89.45

u/l

1.76

303

1610

Venous thromboembolism

234

1436

1.58

9.98

1.3

1.2

97.25

91.31

u/l

0.46

211

1246

Intracranial trauma

226

990

1.61

9.93

1.2

111.09

91.86

u/l

1.19

194

880

Other local infections of skin and subcutaneous tissue

190

2.70

9.87

1.4

1.1

104.55

88.12

u/l

0.45

162

COPD (mode)

121

499

1.91

9.86

1.1

1.2

118.01

75.31

u/l

2.98

102

426

Type 2 diabetes, definitions combined, including avohilmo

375

1511

1.45

9.80

1.2

95.11

85.22

u/l

1.11

326

1321

Acute upper respiratory infections

424

1856

1.41

9.69

1.3

1.2

91.72

88.22

u/l

0.29

384

1618

Injuries to the ankle and foot

272

1595

1.52

9.68

1.4

1.2

93.07

87.27

u/l

0.44

243

1392

Disorders of sclera, cornea, iris and ciliary body

223

1414

1.58

9.67

1.3

1.2

101.36

88.79

u/l

1.06

207

1218

Convulsions, not elsewhere classified

397

2.12

9.64

1.2

116.20

80.01

u/l

1.46

337

Myocardial infarction, strict

191

822

1.66

9.52

1.3

1.2

106.63

88.67

u/l

1.16

166

711

Other and unspecified local infections of skin and subcutaneous tissue

177

2.73

9.49

1.4

1.1

104.49

87.59

u/l

0.45

153

Duodenal ulcer

189

2.66

9.42

1.2

94.22

91.75

u/l

0.06

158

Macular pucker

342

2.21

9.39

1.3

107.32

86.04

u/l

0.87

297

Dipeptidyl peptidase 4 (DPP-4) inhibitors

243

1260

1.55

9.31

1.2

109.68

88.21

u/l

2.33

211

1092

Unspecified fall

207

1282

1.60

9.31

1.2

92.78

91.12

u/l

0.06

185

1112

Injury of unspecified body region

135

2.99

9.30

1.3

1.2

103.03

81.13

u/l

0.73

120

Nonorganic sleeping disorders, excluding more controls

376

2.14

9.28

1.2

76.51

78.17

u/l

0.06

331

ILD, hospital admissions 1, main diag only

288

2.31

9.19

1.1

1.2

97.46

91.59

u/l

0.21

246

Benign neoplasm: Sigmoid colon

438

2.04

9.16

1.3

1.2

82.84

86.59

u/l

0.17

379

Other symptoms and signs involving cognitive functions and awareness

194

1095

1.62

9.15

1.2

86.41

91.53

u/l

0.34

166

965

Acute sinusitis

202

1172

1.60

9.12

1.3

1.2

88.21

85.50

u/l

0.17

189

1019

Other diseases of anus and rectum

125

689

1.82

9.10

1.4

1.2

101.08

84.76

u/l

1.00

110

596

Candidiasis

283

2.31

9.09

1.4

1.2

119.15

83.04

u/l

1.92

246

Degeneration of macula and posterior pole

201

997

1.61

9.08

1.3

1.2

93.47

91.41

u/l

0.11

167

875

Pruritus

217

2.51

9.01

1.1

1.2

91.26

78.78

u/l

0.43

189

Ischaemic heart disease, wide definition

329

1404

1.45

8.96

1.2

96.10

88.70

u/l

0.62

289

1221

Non-allergic asthma (mode)

371

2.12

8.95

1.2

106.82

70.65

u/l

1.48

317

Misadventures to patients during surgical and medical care

311

2.23

8.91

1.3

1.1

121.11

84.07

u/l

1.25

272

Substance abuse, excluding more controls

207

1117

1.58

8.87

1.2

1.3

114.40

88.57

u/l

1.93

174

982

Candidiasis

124

690

1.80

8.84

1.3

1.2

97.37

84.89

u/l

0.78

110

595

Arterial embolism and thrombosis

108

3.18

8.76

1.2

1.1

107.97

97.87

u/l

0.16

Other intervertebral disc disorders

315

1301

1.46

8.73

1.2

88.29

92.85

u/l

0.31

265

1143

Nerve, nerve root and plexus disorders

422

1871

1.38

8.71

1.2

83.89

93.69

u/l

1.43

375

1640

Chronic sinusitis

179

1105

1.62

8.70

1.4

1.2

79.12

89.54

u/l

0.96

165

954

Other specified/unspecified bacterial intestinal infections

119

3.05

8.70

1.2

109.00

81.71

u/l

0.79

104

Other/unspecified rheumatoid arthritis

270

2.31

8.69

1.2

1.1

87.12

80.37

u/l

0.32

235

Urticaria and erythema

153

909

1.69

8.67

1.2

95.16

83.86

u/l

0.45

139

788

Malignant neoplasm of digestive organs

146

669

1.73

8.66

1.2

168.63

87.74

u/l

2.01

128

577

Obesity related asthma

146

860

1.70

8.55

1.3

1.2

85.94

87.34

u/l

0.06

127

738

Coronary atherosclerosis

272

1158

1.49

8.42

1.2

98.66

88.08

u/l

0.82

235

998

Disorders of the thyroid gland

371

1725

1.40

8.41

1.2

84.64

93.93

u/l

1.12

330

1505

Thyrotoxicosis, other and/or unspecified

474

1.95

8.36

1.2

79.65

84.76

u/l

0.19

410

Fall involving bed

4.02

8.36

1.1

1.2

118.06

76.06

u/l

0.90

Multiple myeloma, including Hilmo

3.77

8.35

1.4

1.1

134.96

83.16

u/l

0.97

Dysphagia

104

560

1.86

8.28

1.4

1.2

132.29

81.70

u/l

1.52

478

Other diseases of pericardium

3.85

8.25

1.4

1.1

156.21

92.52

u/l

1.06

Hypothyreosis and Thyroxine purchase for inclusion criteria

366

1717

1.40

8.25

1.2

85.04

91.75

u/l

0.71

331

1493

Pulmonary heart disease, diseases of pulmonary circulation

137

804

1.71

8.15

1.3

1.2

104.45

90.71

u/l

0.83

122

682

Sleep disorders (combined)

450

1739

1.36

8.15

1.2

83.82

92.93

u/l

1.14

386

1537

Disorders of skin appendages

185

1173

1.58

8.07

1.3

1.2

83.87

85.92

u/l

0.11

161

1022

Disorders of adult personality and behaviour

111

616

1.81

8.03

1.2

93.93

82.37

u/l

0.53

540

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

222

1427

1.52

8.03

1.2

72.66

86.58

u/l

1.80

200

1254

Selective serotonin reuptake inhibitors

381

1429

1.39

8.02

1.2

1.3

96.81

92.07

u/l

0.32

328

1263

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

187

2.52

7.99

1.3

1.2

96.05

82.34

u/l

0.53

159

Functional dyspepsia

110

610

1.81

7.98

1.2

86.11

84.70

u/l

0.05

532

Dental caries, including avohilmo

293

1027

1.46

7.96

1.2

100.62

91.44

u/l

0.50

250

906

Major coronary heart disease event

346

1486

1.41

7.93

1.2

104.08

91.20

u/l

1.02

307

1294

Personality disorders

107

591

1.82

7.87

1.1

1.2

94.81

81.81

u/l

0.59

520

Other diseases of hard tissues of teeth

222

745

1.54

7.85

1.2

102.98

92.03

u/l

0.57

187

649

Zoster [herpes zoster]

209

1355

1.52

7.74

1.3

1.2

94.46

87.60

u/l

0.44

181

1175

Lung cancer and mesothelioma

302

2.08

7.74

1.2

107.19

84.16

u/l

0.80

256

Allergic conjunctivitis

229

1498

1.49

7.72

1.2

72.98

86.58

u/l

1.79

204

1321

Concussion

187

975

1.57

7.72

1.2

110.98

92.29

u/l

0.97

161

868

Squamous cell neoplasms and carcinomas of the skin

117

2.92

7.68

1.2

115.03

88.16

u/l

0.92

Phobic anxiety disorders

216

2.37

7.63

1.1

1.2

100.51

86.28

u/l

0.40

189

Ankylosing spondylitis, ICD10

157

2.63

7.61

1.1

92.10

86.30

u/l

0.12

134

Thyrotoxicosis

116

666

1.75

7.52

1.1

1.2

77.07

84.21

u/l

0.36

583

Calculus of kidney and ureter

116

666

1.75

7.51

1.2

1.3

86.83

96.06

u/l

0.51

569

Other arthrosis

202

910

1.54

7.51

1.2

1.3

89.36

98.34

u/l

0.64

185

793

Thiazolidinediones

237

2.29

7.50

1.1

1.2

127.19

82.61

u/l

1.14

206

Cerebral palsy and other paralytic syndromes

225

2.32

7.45

1.4

1.1

95.02

83.87

u/l

0.50

192

Stroke, excluding SAH

244

1211

1.47

7.43

1.3

1.2

111.70

88.57

u/l

1.38

211

1057

Other embolism and thrombosis

270

2.20

7.41

1.2

94.44

83.75

u/l

0.46

231

Diseases of oral cavity, salivary glands and jaws

222

751

1.52

7.40

1.1

1.2

95.47

91.85

u/l

0.16

187

655

Asthma/COPD (KELA code 203)

364

1822

1.37

7.36

1.3

1.2

97.48

89.85

u/l

0.61

319

1605

Soft tissue disorders related to use, overuse and pressure

115

663

1.74

7.35

1.2

71.09

91.35

u/l

2.45

100

573

Procreative management

136

680

1.67

7.32

1.3

1.2

92.21

96.02

u/l

0.12

125

604

Other disorders of bone

399

1.96

7.30

1.3

1.1

83.14

81.50

u/l

0.07

349

Urolithiasis

124

733

1.70

7.25

1.2

1.3

84.12

94.92

u/l

0.68

105

630

Generalized anxiety disorder

280

2.15

7.19

1.2

70.44

82.89

u/l

0.74

246

Cerebrovascular diseases

296

1477

1.41

7.12

1.3

1.2

112.24

89.52

u/l

1.68

251

1291

Urticaria

122

722

1.70

7.11

1.2

94.66

85.80

u/l

0.27

110

633

Spinal stenosis

207

1045

1.51

7.10

1.2

83.10

91.58

u/l

0.64

177

908

Panic disorder

262

2.18

7.09

1.3

1.2

88.16

80.59

u/l

0.28

227

Hypothyroidism, other/unspecified

343

1640

1.38

7.09

1.2

84.84

92.80

u/l

0.86

309

1430

Nonorganic sleeping disorders

419

1.92

7.00

1.2

76.51

85.27

u/l

0.41

369

Fall on same level involving ice and snow

226

1547

1.46

7.00

1.2

94.51

88.18

u/l

0.40

205

1341

Shoulder lesions

285

1216

1.42

7.00

1.2

87.09

95.75

u/l

0.76

244

1064

Postmenopausal osteoporosis with pathological fracture

141

2.65

6.97

1.2

129.70

82.31

u/l

0.92

123

Neurological diseases

325

1170

1.40

6.97

1.2

89.34

98.30

u/l

0.61

282

1041

Malignant neoplasm of prostate

276

1.91

6.94

1.8

1.2

107.61

103.21

u/l

0.09

234

Other disorders of veins

172

1109

1.55

6.92

1.2

85.66

83.93

u/l

0.10

146

955

malignant neoplasm of male genital organs

291

1.89

6.88

1.8

1.2

111.06

103.95

u/l

0.16

243

Benign neoplasm: Transverse colon

234

2.24

6.84

1.3

1.2

95.28

85.97

u/l

0.26

203

Disorders of vitreous body

214

1406

1.47

6.83

1.3

1.2

83.36

87.89

u/l

0.36

190

1218

Psoriasis vulgaris

423

1.90

6.82

1.2

101.49

90.77

u/l

0.33

361

Polymyalgia rheumatica

287

2.10

6.78

1.1

1.2

71.94

86.58

u/l

0.85

249

Memory loss

179

2.42

6.76

1.2

109.61

94.05

u/l

0.32

153

Diabetic maculopathy

276

2.09

6.75

1.4

1.2

114.55

103.74

u/l

0.33

238

Ankylosing spondylitis

167

2.47

6.75

1.1

1.2

92.10

88.62

u/l

0.07

132

Arthrosis

257

978

1.44

6.75

1.2

1.3

84.69

99.86

u/l

1.52

227

855

Benign neoplasm: Rectum

406

1.91

6.64

1.2

98.22

87.63

u/l

0.39

350

Disorders of vitreous body and globe

218

1438

1.46

6.63

1.3

1.2

83.42

87.71

u/l

0.34

192

1246

Retinal vascular disorders

244

2.18

6.61

1.2

104.98

100.24

u/l

0.11

214

Superficial injury of head

522

1.79

6.56

1.2

102.18

82.01

u/l

1.24

452

Delirium, not induced by alcohol and other psychoactive substances

238

2.19

6.54

1.1

1.2

87.20

89.65

u/l

0.08

201

Other viral diseases

104

603

1.72

6.50

1.2

90.64

95.46

u/l

0.18

529

Mental and behavioural disorders due to psychoactive substance use

214

1362

1.46

6.48

1.2

1.3

111.43

93.46

u/l

1.14

181

1201

Hydronephrosis

189

2.34

6.46

1.3

1.2

88.65

75.32

u/l

0.46

159

Substance abuse

207

1330

1.47

6.43

1.2

1.3

114.40

93.44

u/l

1.38

174

1172

Inflammatory diseases of the central nervous system

153

2.50

6.42

1.2

1.1

93.59

87.02

u/l

0.14

132

Unspecified acute lower respiratory infection

280

2.08

6.42

1.2

110.62

88.51

u/l

0.90

233

Biguanides

375

1712

1.34

6.38

1.2

104.50

87.64

u/l

1.95

330

1498

Caries of enamel

335

1789

1.35

6.34

1.3

1.2

87.20

87.78

u/l

0.04

300

1566

Pacemaker

122

714

1.64

6.32

1.3

1.2

113.67

96.87

u/l

1.00

112

607

Abnormalities of heart beat

135

830

1.60

6.30

1.2

1.3

92.28

82.64

u/l

0.55

120

715

Allergic asthma (mode), excluding more controls

404

1.87

6.29

1.3

1.2

88.88

70.00

u/l

1.07

345

Benign neoplasm of other and unspecified endocrine glands

296

2.04

6.28

1.3

1.2

79.67

85.07

u/l

0.23

262

Retinal vascular occlusion

243

2.15

6.27

1.2

105.40

98.03

u/l

0.18

213

Coronary artery bypass grafting

378

1.80

6.27

1.3

124.59

95.56

u/l

1.03

326

Myalgia

530

1.76

6.26

1.3

1.2

75.15

89.50

u/l

1.22

461

Fracture of forearm

229

1469

1.43

6.26

1.2

77.53

85.42

u/l

0.81

198

1287

Benign neoplasm: Rectum, anus and anal canal

465

1.81

6.24

1.2

103.85

87.04

u/l

0.61

399

Transport accidents

156

869

1.55

6.22

1.3

1.2

93.34

85.68

u/l

0.45

130

766

Dilated cardiomyopathy

232

2.17

6.14

1.1

1.2

135.32

94.74

u/l

1.55

196

Polyuria

468

1.80

6.12

1.4

1.2

119.79

91.80

u/l

0.83

399

Acquired haemolytic anaemia

4.16

6.10

1.3

1.2

121.50

75.82

u/l

1.60

Retinal detachments and breaks

142

910

1.57

6.09

1.2

92.86

88.53

u/l

0.22

121

793

Vitamin deficiency

3.04

6.08

1.5

1.1

98.04

74.80

u/l

0.53

Vitamin deficiency, wide

3.04

6.08

1.5

1.1

98.04

74.80

u/l

0.53

Ischaemic Stroke, excluding all haemorrhages

221

1145

1.44

6.07

1.2

106.69

89.60

u/l

1.05

190

998

Malignant melanoma

253

2.10

6.06

1.3

1.2

105.98

83.90

u/l

0.87

211

Caries of dentine, including avohilmo

304

1131

1.38

6.03

1.2

99.22

88.56

u/l

0.74

258

1000

Exclusions for E4_PCOS_CONSORTIUM

285

1295

1.38

6.01

1.3

1.2

83.31

84.75

u/l

0.10

253

1136

In situ neoplasms

156

1025

1.53

5.99

1.2

99.12

86.36

u/l

0.82

142

887

Stomatitis and related lesions

443

1.81

5.96

1.2

146.01

86.24

u/l

0.60

391

Molar incisor enamel hypoplasia

4.09

5.94

1.7

1.1

392.31

80.34

u/l

0.68

Nonischemic cardiomyopathy

178

2.31

5.90

1.1

1.3

97.91

87.73

u/l

0.25

151

Deforming dorsopathies

114

699

1.64

5.89

1.3

1.2

74.88

86.31

u/l

0.94

106

604

Fibroblastic disorders

533

1.73

5.88

1.3

97.04

92.87

u/l

0.14

462

Degenerative macular diseases

243

2.11

5.88

1.2

84.52

88.50

u/l

0.14

214

Open wound of head

195

1296

1.45

5.86

1.2

97.29

93.10

u/l

0.20

164

1143

Injuries to the elbow and forearm

274

1763

1.37

5.79

1.2

76.77

88.72

u/l

1.75

235

1542

Benign neoplasm: Adrenal gland

168

2.34

5.74

1.3

1.1

84.00

83.07

u/l

0.02

147

Use of pramipexole

575

1.69

5.73

1.3

1.2

77.46

87.40

u/l

0.54

496

Unstable angina pectoris

136

686

1.57

5.71

1.2

1.3

104.22

91.82

u/l

0.58

115

585

COPD, hospital admissions 3, with asthma pneumonia sepsis

102

521

1.68

5.68

1.1

1.2

110.76

99.52

u/l

0.42

446

Fissure and fistula of anal and rectal regions

517

1.73

5.65

1.1

1.2

79.78

83.78

u/l

0.18

444

Coxarthrosis [arthrosis of hip](FG)

201

981

1.44

5.62

1.2

87.13

93.16

u/l

0.40

179

858

Malignant melanoma, including Hilmo

338

1.90

5.56

1.2

102.86

82.22

u/l

0.97

287

Cytomegaloviral disease

3.86

5.55

1.1

1.2

81.31

92.26

u/l

0.20

Hernia of abdominal wall

167

1132

1.48

5.55

1.3

1.2

102.50

91.35

u/l

0.62

152

968

Pulmonary embolism

117

734

1.60

5.53

1.3

1.2

96.84

91.19

u/l

0.26

107

622

Trochanteric bursitis

339

1.90

5.52

1.1

1.2

83.09

81.50

u/l

0.07

303

Aortic aneurysm

431

1.78

5.50

1.2

1.3

108.97

94.53

u/l

0.63

367

Multiple myeloma

4.66

5.50

1.4

1.1

122.94

97.29

u/l

0.27

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

4.66

5.50

1.4

1.1

122.94

97.29

u/l

0.27

Fracture of skull and facial bones

440

1.78

5.50

1.2

113.75

83.67

u/l

1.12

387

Carbimazole or st.post thyroidectomy, condition for graves disease

522

1.71

5.48

1.1

1.2

75.96

81.27

u/l

0.18

460

Keratitis

133

862

1.55

5.47

1.4

1.2

97.96

86.78

u/l

0.60

122

739

Pneumonia due to other infectious organisms, not elsewhere classified

3.50

5.46

1.1

1.2

88.28

71.21

u/l

0.53

Diseases of pulp and periapical tissues and dental caries

248

911

1.40

5.44

1.2

102.69

94.22

u/l

0.38

214

798

Fenamates

236

1.90

5.38

1.1

1.3

74.25

102.40

u/l

2.04

214

Other disorders of skin and subcutaneous tissue, not elsewhere classified

293

1.95

5.37

1.3

1.2

93.27

84.80

u/l

0.27

251

Other and unspecified injuries of head

118

2.56

5.37

1.1

1.2

81.96

80.29

u/l

0.04

104

Lumbar disc prolapse

229

1262

1.39

5.35

1.1

1.2

92.39

92.06

u/l

0.01

192

1108

DVT of lower extremities and pulmonary embolism

165

1120

1.47

5.35

1.3

1.2

92.19

92.37

u/l

0.01

154

963

Monoamine oxidase A inhibitors

273

1.99

5.34

1.2

89.80

85.12

u/l

0.19

242

Allergic asthma (mode)

427

1.77

5.33

1.3

1.2

88.88

72.00

u/l

0.91

366

Other viral diseases

128

822

1.55

5.31

1.2

85.79

86.27

u/l

0.02

118

721

Pulmonary heart disease

117

742

1.58

5.31

1.3

1.2

96.84

91.39

u/l

0.25

107

627

Cystic fibrosis with pulmonary manifestations

+∞

5.29

2.6

0.0

177.20

—

u/l

—

Other and unspecified urticaria

431

1.77

5.28

1.2

96.01

84.32

u/l

0.23

380

Stroke, including SAH

244

1289

1.38

5.23

1.3

1.2

109.99

88.69

u/l

1.26

211

1125

Injuries to the shoulder and upper arm

317

1940

1.32

5.22

1.2

97.51

89.86

u/l

0.54

277

1699

Myeloproliferative diseases

163

2.28

5.20

1.3

1.2

103.53

82.94

u/l

0.47

144

Faecal incontinence

215

2.11

5.20

1.3

1.2

96.14

76.43

u/l

0.63

187

Other disorders of the musculoskeletal system and connective tissue

332

1.88

5.19

1.3

1.2

82.49

85.92

u/l

0.14

290

Malignant neoplasm of prostate, including Hilmo

285

1.76

5.18

1.8

1.2

101.57

102.27

u/l

0.01

239

Mental and behavioural disorders due to alcohol

174

1158

1.45

5.18

1.1

1.3

113.14

95.70

u/l

0.85

146

1023

Injury, poisoning and certain other consequences of external causes

195

678

1.44

5.14

1.2

97.47

90.04

u/l

0.29

168

608

Thyrotoxicosis with toxic multinodular goitre

127

2.46

5.13

1.2

95.15

73.21

u/l

0.39

111

Symptoms and signs involving the nervous and musculoskeletal systems

217

1567

1.39

5.12

1.3

1.2

109.07

88.79

u/l

0.91

180

1370

Viral infections characterized by skin and mucous membrane lesions

156

1062

1.47

5.09

1.2

87.08

89.17

u/l

0.11

146

908

Other pulmonary heart/vessel disease

2.86

5.09

1.3

1.1

158.89

75.24

u/l

1.85

Psoriatic arthropathies

197

2.14

5.09

1.2

67.43

87.49

u/l

1.47

168

Malignant neoplasm of respiratory system and intrathoracic organs

330

1.80

5.05

1.1

1.2

110.68

93.23

u/l

0.48

283

COPD, hospital admission 2, with asthma infections

118

648

1.56

5.04

1.1

1.3

106.14

101.04

u/l

0.18

100

556

Radiculopathy

379

1.80

5.03

1.1

1.2

71.90

87.24

u/l

1.29

318

Mental and behavioural disorders due to alcohol, excluding acute intoxication

151

1020

1.48

5.03

1.2

1.3

115.09

97.15

u/l

0.81

125

890

Retinal detachment with retinal break

266

1.96

5.00

1.2

88.66

86.59

u/l

0.06

231

Episodal and paroxysmal disorders

413

1647

1.28

5.00

1.2

91.23

95.94

u/l

0.34

352

1454

Intracranial injury

206

1400

1.39

4.99

1.2

109.34

87.50

u/l

1.46

175

1236

Palmar fascial fibromatosis [Dupuytren]

294

1.91

4.99

1.3

101.42

100.83

u/l

0.01

247

Other disorders of lacrimal gland

144

972

1.49

4.95

1.2

82.23

84.81

u/l

0.13

122

847

Conjunctivitis (acute, non atopic)

104

651

1.60

4.94

1.2

80.12

86.17

u/l

0.29

567

Sequelae of injuries of lower limb

193

2.14

4.93

1.2

92.89

86.81

u/l

0.13

166

Melanocytic naevi

112

717

1.57

4.92

1.3

1.2

84.51

86.72

u/l

0.09

623

Psychiatric diseases

368

1426

1.29

4.91

1.2

93.80

90.20

u/l

0.20

317

1254

Specific personality disorders

486

1.69

4.90

1.1

1.2

98.13

82.46

u/l

0.54

424

Secondary right heart disease

2.94

4.88

1.3

1.2

158.88

75.11

u/l

1.58

Special screening examination for infectious and parasitic diseases

283

1.80

4.86

1.2

75.98

80.73

u/l

0.20

244

Cytomegalovirus infection, IBD co-morbidity

4.27

4.84

1.1

81.31

90.66

u/l

0.16

Visual disturbances and blindness

195

1398

1.40

4.84

1.2

95.10

89.44

u/l

0.24

174

1211

Zoster [herpes zoster]

436

1.73

4.82

1.2

95.65

89.48

u/l

0.22

376

Haemolytic anaemias

3.09

4.80

1.2

136.16

81.13

u/l

1.10

Pain in thoracic spine

349

1.81

4.77

1.2

75.45

86.00

u/l

0.47

299

Basal cell carcinoma, including avohilmo

158

746

1.46

4.76

1.3

1.2

99.11

85.71

u/l

0.74

139

641

Basal cell carcinoma

152

716

1.47

4.75

1.3

1.2

100.84

86.55

u/l

0.76

132

619

Ingrowing nail

2.68

4.75

1.4

1.1

97.50

77.37

u/l

0.45

Other and unspecified vascular occlusions

183

2.14

4.74

1.2

100.97

94.94

u/l

0.14

162

Hypoplasia of dental enamel , including avohilmo

4.45

4.73

1.7

1.1

405.67

63.86

u/l

0.71

Recurrent aphthous stomatitis , including avohilmo

301

1.87

4.68

1.2

166.53

83.85

u/l

0.58

265

Subjective visual disturbances

100

632

1.59

4.67

1.2

86.73

86.42

u/l

0.01

547

Gonarthrosis [arthrosis of knee](FG)

262

1138

1.34

4.65

1.2

87.61

95.39

u/l

0.58

222

997

Emotionally unstable personality disorder

198

2.08

4.63

1.1

1.2

83.23

85.22

u/l

0.08

172

Other disorders of eye and adnexa

302

1.86

4.63

1.4

1.1

82.00

86.17

u/l

0.13

267

Hyperaldosteronism

3.24

4.63

1.2

1.1

88.25

78.32

u/l

0.33

Hereditary hypogammaglobulinemia

14.67

4.63

1.1

1.2

120.86

56.20

u/l

—

Glucagon-like peptide-1 (GLP-1) analogues

112

729

1.54

4.60

1.2

1.3

90.90

84.17

u/l

0.32

103

633

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

112

729

1.54

4.60

1.2

1.3

90.90

84.17

u/l

0.32

103

633

Malignant neoplasm of oral cavity, including Hilmo

2.92

4.60

1.3

1.1

107.36

84.58

u/l

0.36

Vocal cord dysfunction

159

2.15

4.60

1.2

71.73

69.32

u/l

0.10

135

Unspecified lump in breast

429

1.71

4.54

1.3

1.2

68.05

77.82

u/l

0.68

381

Abscess of anal and rectal regions

141

2.28

4.53

1.2

1.1

75.04

88.45

u/l

0.28

118

Disturbances of skin sensation

102

653

1.57

4.52

1.3

1.2

75.67

88.10

u/l

1.17

567

Benign neoplasm: Ascending colon

312

1.84

4.51

1.2

111.23

87.10

u/l

0.78

271

Dermatophytosis

214

1576

1.36

4.51

1.2

82.40

91.13

u/l

0.92

191

1372

Erosion of teeth , including avohilmo

529

1.63

4.50

1.2

90.63

86.89

u/l

0.13

464

Sulfonylureas

131

701

1.49

4.48

1.3

131.49

89.01

u/l

2.55

119

598

Visual disturbances

180

1292

1.40

4.48

1.2

96.18

89.40

u/l

0.28

159

1121

Malignant neoplasm of bronchus and lung, including Hilmo

345

1.73

4.48

1.2

99.73

93.79

u/l

0.17

294

Myocardial infarction, with ST-elevation

349

1.78

4.48

1.2

1.3

131.48

95.57

u/l

0.97

288

Other malignant neoplasms of skin (=non-melanoma skin cancer)

156

741

1.45

4.47

1.3

1.2

100.21

86.72

u/l

0.71

134

637

Other and unspecified mood [affective] disorders

2.59

4.47

1.1

1.2

86.96

87.59

u/l

0.01

Infection due to other mycobacteria

5.87

4.46

1.9

1.2

149.55

73.86

u/l

1.09

Malignant neoplasm of skin

173

838

1.42

4.45

1.3

1.2

100.90

85.73

u/l

0.95

149

721

Substance use, excluding alcohol

409

1.72

4.45

1.2

101.93

90.76

u/l

0.50

356

Atopic dermatitis

199

1187

1.38

4.43

1.3

1.2

85.11

87.67

u/l

0.12

177

1049

Coxarthrosis

179

841

1.41

4.41

1.2

1.3

88.76

97.33

u/l

0.55

159

734

Malignant melanoma of skin, including Hilmo

258

1.91

4.38

1.3

1.2

98.52

83.03

u/l

0.70

218

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

167

799

1.42

4.35

1.3

1.2

97.71

85.95

u/l

0.64

142

687

Anaemia in chronic diseases classified elsewhere

4.29

4.33

1.4

1.2

108.14

95.04

u/l

0.13

Renal agenesis and other reduction defects of kidney

12.02

4.31

1.3

1.2

64.29

64.67

u/l

—

Other diseases of lip and oral mucosa

153

1076

1.43

4.30

1.2

74.01

85.35

u/l

1.32

128

937

Behavioural syndromes associated with physiological disturbances and physical factors

338

1884

1.27

4.30

1.2

87.32

88.64

u/l

0.08

288

1663

Alcohol use disorder, ICD-based

137

945

1.45

4.28

1.2

1.3

105.61

97.87

u/l

0.31

112

822

Appendectomy

230

1653

1.33

4.26

1.3

1.2

104.61

87.67

u/l

1.48

212

1439

Enthesopathies of lower limb, excluding foot

537

1.61

4.26

1.3

1.2

87.63

91.62

u/l

0.14

463

Mental and behavioural disorders due to sedatives or hypnotics

120

2.35

4.24

1.0

1.2

99.48

83.06

u/l

0.54

107

Other diseases of oesophagus

165

2.13

4.24

1.4

1.1

57.90

81.27

u/l

1.76

140

Disorders of eyelid, lacrimal system and orbit

319

1897

1.28

4.24

1.3

1.2

87.26

93.46

u/l

0.41

277

1665

Acute pharyngitis

238

1.92

4.22

1.5

1.2

108.47

85.62

u/l

0.29

201

Anogenital herpesviral [herpes simplex] infection

159

2.15

4.20

1.1

1.2

69.69

83.39

u/l

0.50

140

Syphilis

3.30

4.20

1.3

1.2

139.87

75.33

u/l

0.92

Syphilis

3.30

4.20

1.3

1.2

139.87

75.32

u/l

0.92

Corneal scars and opacities

3.29

4.20

1.2

1.1

99.47

74.55

u/l

0.62

Malignant neoplasm of small intestine, including Hilmo

3.44

4.19

1.1

144.29

88.75

u/l

0.84

Gonarthrosis

223

942

1.35

4.19

1.2

1.3

89.46

99.07

u/l

0.66

191

824

Amputation of thigh

3.44

4.19

1.6

1.1

198.93

102.75

u/l

1.44

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.84

4.18

1.3

1.1

155.89

144.02

u/l

0.04

Phlebitis and thrombophlebitis (not including DVT)

540

1.60

4.17

1.2

107.16

82.87

u/l

1.88

463

Single spontaneous delivery

698

0.63

4.17

1.2

85.35

86.32

u/l

0.03

622

Iridocyclitis

533

1.60

4.15

1.2

110.96

87.66

u/l

1.26

458

Localized swelling, mass and lump of skin and subcutaneous tissue

120

812

1.48

4.15

1.2

94.67

87.72

u/l

0.32

110

693

Multiple myeloma and malignant plasma cell neoplasms

2.49

4.13

1.4

1.1

121.46

88.21

u/l

0.61

Ventral hernia

589

1.57

4.12

1.3

1.2

94.90

87.59

u/l

0.26

505

Superficial injury of hip and thigh

278

1.84

4.11

1.3

1.1

101.58

87.47

u/l

0.38

236

Diffuse large B-cell lymphoma, including Hilmo

2.72

4.09

1.2

1.1

282.40

84.81

u/l

0.54

Diffuse large B-cell lymphoma, helper endpoint

2.72

4.09

1.2

1.1

282.40

84.81

u/l

0.54

Diffuse large B-cell lymphoma

2.72

4.09

1.2

1.1

282.40

84.81

u/l

0.54

Dental operations

230

882

1.34

4.07

1.2

100.89

93.31

u/l

0.39

196

767

Later onset COPD, excluding more controls

304

1.71

4.04

1.2

104.75

80.33

u/l

1.03

258

Other follicular disorders

123

2.29

4.03

1.3

1.2

100.15

88.03

u/l

0.14

110

Acute and subacute iridocyclitis

437

1.65

4.02

1.2

111.60

88.18

u/l

1.26

375

Follicular cysts of skin and subcutaneous tissue

407

1.68

4.00

1.3

1.2

83.00

90.27

u/l

0.30

347

Other enthesopathies

109

730

1.50

3.98

1.3

1.2

91.26

91.45

u/l

0.01

634

Angina pectoris

212

1055

1.34

3.95

1.2

98.01

87.44

u/l

0.71

189

916

Other headache syndromes

155

1110

1.40

3.95

1.3

1.2

77.91

88.42

u/l

0.93

137

970

Traumatic subdural haemorrhage

236

1.88

3.93

1.3

1.2

119.50

99.13

u/l

0.54

202

Delivery

698

0.64

3.92

1.2

84.85

86.32

u/l

0.05

622

Hallux rigidus

327

1.75

3.92

1.1

1.3

76.55

84.91

u/l

0.40

280

Anterior Iridocyclitis

471

1.62

3.92

1.2

112.07

88.09

u/l

1.33

407

Otitis externa

511

1.59

3.88

1.4

1.2

98.77

87.30

u/l

0.45

442

Hemiplegia

2.52

3.88

1.3

1.2

109.47

78.83

u/l

0.76

Other disorders starting during childhood or adolescence

3.11

3.86

1.4

1.1

151.07

169.80

u/l

0.05

Early onset COPD

536

1.57

3.84

1.1

1.3

113.36

91.13

u/l

0.83

461

Seborrhoeic dermatitis

172

2.04

3.84

1.5

1.1

73.96

86.49

u/l

0.66

148

Sleep apnoea

347

1796

1.25

3.83

1.2

77.37

94.11

u/l

3.43

306

1574

Superficial injury of lower leg

568

1.55

3.83

1.3

1.2

79.49

87.95

u/l

0.58

499

Infections with a predominantly sexual mode of transmission

655

1.51

3.82

1.2

101.27

81.60

u/l

0.84

578

Idiopathic thrombocytopenic purpura

3.09

3.81

1.5

1.1

263.00

82.45

u/l

1.08

COPD

161

952

1.39

3.80

1.2

106.69

90.54

u/l

0.97

137

822

Thyrotoxicosis with diffuse goitre

323

1.74

3.79

1.1

1.2

69.57

80.27

u/l

0.48

286

Viral warts

460

1.61

3.78

1.2

69.65

87.20

u/l

1.64

403

Arthropathic psoriasis

243

1.86

3.78

1.2

1.1

76.95

88.89

u/l

0.45

209

Other disorders starting during childhood or adolecense, excluding more controls

3.07

3.76

1.4

1.2

151.07

167.10

u/l

0.05

Superficial injury of abdomen, lower back and pelvis

287

1.78

3.75

1.4

1.2

105.02

87.88

u/l

0.25

241

Maternal care for other conditions predominantly related to pregnancy

422

1.63

3.73

1.2

79.09

80.06

u/l

0.06

373

Covid-19 suspected case

462

1.61

3.72

1.3

1.2

102.14

80.22

u/l

1.09

407

Other enthesopathy of foot (+metatarsalgia)

223

1.89

3.72

1.3

1.2

90.91

79.60

u/l

0.31

203

COPD related to multimorbidity

138

825

1.42

3.72

1.1

1.3

107.63

97.77

u/l

0.44

117

710

Metatarsalgia

203

1.93

3.66

1.3

1.2

86.22

80.40

u/l

0.13

186

Other and unspecified follicular disorders

2.71

3.66

1.2

74.70

85.67

u/l

—

Fracture of foot, except ankle

527

1.56

3.65

1.5

1.2

98.61

84.34

u/l

0.51

464

Sequelae of cerebrovascular disease

126

760

1.43

3.65

1.2

124.35

91.14

u/l

1.19

107

654

D07AA Corticosteroids, weak (group I)

298

1.75

3.59

1.1

1.2

92.37

98.12

u/l

0.13

258

Other respiratory disorders and diseases

443

1.61

3.59

1.3

1.2

137.42

95.32

u/l

1.10

377

Other diseases of the respiratory system

443

1.61

3.59

1.3

1.2

137.42

95.32

u/l

1.10

377

Ankylosing spondylitis, strict definition

2.76

3.59

1.1

81.65

87.48

u/l

0.13

Other congenital malformations

240

1.84

3.59

1.3

1.2

92.45

84.72

u/l

0.17

213

Lung diseases due to external agents

262

1.80

3.58

1.1

1.2

104.62

95.04

u/l

0.37

219

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

567

1.53

3.58

1.2

106.71

79.71

u/l

1.10

501

Carpal tunnel syndrome

231

1573

1.30

3.56

1.3

1.2

75.80

88.44

u/l

1.89

209

1370

Diseases of salivary glands

118

823

1.44

3.55

1.3

1.2

83.64

85.19

u/l

0.08

106

714

Sleep apnoea, including avohilmo

366

1839

1.23

3.55

1.2

75.83

94.64

u/l

4.48

320

1614

Voice disturbances

103

701

1.47

3.53

1.3

1.2

89.16

84.15

u/l

0.23

605

Symptoms and signs involving speech and voice

125

884

1.42

3.50

1.3

1.2

86.58

86.06

u/l

0.02

113

763

Alcohol dependence

567

1.52

3.44

1.1

1.3

113.43

99.70

u/l

0.41

486

Congenital malformations of genital organs

158

2.02

3.44

1.1

1.2

120.59

76.60

u/l

0.42

139

Other surgical follow-up care

3.00

3.41

1.3

1.1

84.36

72.30

u/l

0.26

Restless leg syndrome

296

1.73

3.41

1.1

1.2

61.66

84.09

u/l

2.60

260

Fall on and from stairs and steps

641

1.49

3.41

1.2

108.00

87.83

u/l

0.88

552

Sleep disorders

317

1844

1.24

3.40

1.2

85.13

88.20

u/l

0.22

268

1625

Other chronic obstructive pulmonary disease

153

924

1.37

3.39

1.2

108.32

90.71

u/l

1.03

130

800

Somatoform disorder

373

1.64

3.37

1.2

88.40

84.26

u/l

0.14

330

Rotator cuff syndrome

212

1167

1.30

3.37

1.3

1.2

91.13

94.16

u/l

0.16

184

1021

Complications of the puerperium, not elsewhere classified

2.85

3.36

1.5

1.1

74.33

80.77

u/l

0.14

Pneumonia derived septicemia

2.73

3.33

1.6

1.2

322.56

75.56

u/l

0.53

Injuries to the wrist and hand

354

2002

1.23

3.32

1.2

89.82

91.53

u/l

0.11

309

1761

Late syphilis

4.42

3.32

1.5

1.2

113.80

75.44

u/l

—

N06DA Anticholinesterases

718

0.61

3.32

1.1

1.2

81.51

95.83

u/l

0.84

613

Use of anticholinesterases

718

0.61

3.32

1.1

1.2

81.51

95.83

u/l

0.84

613

Other diseases of gallbladder

2.43

3.31

1.2

112.55

72.44

u/l

1.02

Alcohol-induced chronic pancreatitis

128

2.12

3.29

1.1

1.2

138.59

97.57

u/l

0.71

110

Psoriatic arthropathies, ICD10

233

1.81

3.28

1.2

1.1

67.43

87.26

u/l

1.70

202

Delivery, wide proxy

558

0.64

3.28

1.3

1.2

74.14

84.04

u/l

1.02

496

Sequelae of injuries, of poisoning and of other consequences of external causes

550

1.51

3.27

1.2

86.00

87.06

u/l

0.03

480

Other disorders of iris and ciliary body

3.05

3.26

1.3

1.2

98.38

76.11

u/l

0.95

Malignant neoplasm of bronchus and lung

285

1.66

3.25

1.1

1.2

101.25

86.32

u/l

0.42

244

Other inflammation of eyelid

316

1.68

3.24

1.4

1.2

101.29

81.06

u/l

0.28

278

Poisoning by drugs, medicaments and biological substances

535

1.52

3.24

1.2

109.80

83.79

u/l

1.50

467

Malignant neoplasm of head and neck

129

2.10

3.23

1.3

1.2

114.15

91.55

u/l

0.35

111

Insomnia

307

1807

1.24

3.22

1.2

85.28

88.22

u/l

0.20

257

1591

Other epidermal thickening

2.52

3.21

1.4

1.2

128.50

76.94

u/l

0.84

Superficial injury of wrist and hand

425

1.58

3.21

1.2

78.60

85.48

u/l

0.39

375

Poisoning by medicine

473

1.55

3.19

1.2

110.52

84.26

u/l

1.30

413

Disorders of breast

187

1299

1.31

3.16

1.2

74.92

82.94

u/l

0.63

167

1151

Abnormal findings in secretions and smears from cervix uteri vagina vulva

172

980

1.33

3.15

1.2

74.32

82.33

u/l

0.72

150

877

Bipolar affective disorders

381

1.60

3.12

1.2

105.56

79.53

u/l

1.13

330

Infections with a predominantly sexual mode of transmission

120

801

1.40

3.12

1.2

104.41

83.09

u/l

1.09

106

713

Disorders of lacrimal system

162

1217

1.33

3.11

1.2

82.20

85.16

u/l

0.17

137

1054

Other chronic obstructive pulmonary disease, including avohilmo

190

1205

1.30

3.11

1.1

1.2

103.39

93.35

u/l

0.59

163

1047

Other neurological diseases

259

1624

1.25

3.09

1.2

95.76

91.89

u/l

0.21

228

1409

Malignant neoplasm of small intestine

4.04

3.09

1.2

1.1

135.50

80.45

u/l

—

Corneal ulcer

406

1.58

3.08

1.5

1.2

90.12

86.37

u/l

0.12

350

Melanocytic naevi of lower limb, including hip

2.39

3.06

1.6

1.1

96.79

78.56

u/l

0.45

Ptosis of eyelid

255

1.73

3.00

1.2

107.62

80.73

u/l

0.90

227

Rheumatic fever with heart involvement

10.23

2.99

1.2

65.60

74.40

u/l

—

Other crystal arthropathies

3.89

2.99

1.1

59.30

91.90

u/l

—

Necrosis of pulp, including avohilmo

190

1470

1.29

2.96

1.2

1.3

83.76

88.20

u/l

0.37

169

1285

Other blood glucose lowering drugs, excl. Insulins

387

1.58

2.95

1.2

87.81

85.92

u/l

0.05

332

Disorders of tooth development and eruption

242

1.68

2.95

1.4

1.2

82.67

87.29

u/l

0.14

216

Barrett oesophagus

2.29

2.94

1.2

1.1

75.33

87.94

u/l

0.37

Complications of labour and delivery

149

1101

0.75

2.92

1.2

71.38

81.56

u/l

1.16

133

979

Fracture at wrist and hand level

111

795

1.40

2.92

1.1

1.2

87.09

88.82

u/l

0.05

694

Unspecific neurodegenerative disorder

801

0.68

2.92

1.1

1.2

85.82

95.17

u/l

0.39

698

Other diseases of upper respiratory tract

401

1745

1.20

2.91

1.3

1.2

81.19

97.32

u/l

2.73

351

1531

Adverse effects, not elsewhere classified

436

1.54

2.91

1.3

1.2

76.18

85.47

u/l

0.51

388

Sensorineural hearing loss

186

1623

0.78

2.91

1.3

1.2

85.37

94.35

u/l

0.64

169

1410

Other viral diseases, not elsewhere classified

570

1.47

2.91

1.3

1.2

87.77

93.78

u/l

0.22

497

Malignant neoplasm of colon

273

1.69

2.89

1.1

1.2

226.85

80.63

u/l

0.88

230

COPD, hospital admissions

153

975

1.33

2.89

1.2

108.32

95.96

u/l

0.62

130

841

Other psoriatic arthropathies

221

1.77

2.89

1.2

1.1

68.59

88.22

u/l

1.54

190

Generalized skin eruption due to drugs and medicaments

2.52

2.87

1.1

126.63

72.04

u/l

1.44

Mouth breathing

133

986

1.35

2.85

1.2

1.3

88.26

91.67

u/l

0.15

122

851

Pregnancy, childbirth and the puerperium

465

0.64

2.79

1.3

1.2

80.66

83.18

u/l

0.16

413

Carcinoma in situ of skin of ear and external auricular canal

3.62

2.79

1.0

1.2

97.00

113.45

u/l

—

Problems related to lifestyle

158

1.90

2.79

1.1

110.62

85.71

u/l

0.47

136

Ocular pain

159

1.89

2.75

1.2

67.92

82.57

u/l

0.57

139

Bacterial, viral and other infectious agents

159

1.89

2.75

1.1

1.2

81.74

91.60

u/l

0.30

139

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

114

828

1.37

2.74

1.3

1.2

81.01

82.96

u/l

0.13

101

731

Colonic or urogenital fistula

682

1.41

2.71

1.1

1.2

80.68

90.22

u/l

0.53

581

Pneumonia due to Streptococcus pneumoniae

2.51

2.70

1.6

1.1

114.20

79.72

u/l

0.38

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

189

1.81

2.70

1.4

1.1

81.24

83.25

u/l

0.06

165

COPD, early/later onset

153

983

1.31

2.69

1.2

108.32

95.82

u/l

0.63

130

848

Hypothyroidism, strict autoimmune, 3 medication purchases required

296

1643

1.22

2.68

1.2

85.12

89.82

u/l

0.46

268

1427

Malignant neoplasm of colon, including Hilmo

358

1.57

2.65

1.1

1.2

199.47

84.58

u/l

0.81

305

Melanocytic naevi of trunk

235

1.71

2.64

1.1

81.57

87.02

u/l

0.16

204

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.80

2.63

1.2

58.17

73.05

u/l

0.44

Dislocation, sprain and strain of joints and ligaments of thorax

2.48

2.62

1.3

1.2

78.73

78.21

u/l

0.01

Crystal arthropathies, rheuma endpoint

3.37

2.61

1.1

1.0

59.30

74.58

u/l

—

Superficial injury of shoulder and upper arm

221

1.72

2.60

1.2

101.12

88.03

u/l

0.17

189

Oter anti-inflammatory and antirheumatic agents, non-steroids

292

1.48

2.57

1.2

85.60

104.04

u/l

0.89

263

Other endocrine disorders

2.25

2.56

1.4

1.1

270.11

97.16

u/l

0.39

Aggressive periodontitis

2.89

2.55

1.2

80.00

77.24

u/l

0.08

Other specified disorders of kidney and ureter

2.44

2.54

1.1

1.2

305.47

79.88

u/l

0.43

Abnormal spermatozoa

225

0.40

2.54

1.1

1.3

138.33

96.97

u/l

—

182

Diseases of external ear

113

837

1.35

2.51

1.3

1.2

89.51

89.27

u/l

0.01

717

Chondropathies

332

1.57

2.50

1.2

88.00

86.08

u/l

0.06

287

Other skin changes

429

1.50

2.48

1.2

92.25

93.12

u/l

0.03

367

Erythema multiforme

2.69

2.46

1.1

64.83

73.93

u/l

0.23

severe traumatic brain injury, does not include concussion

471

1.47

2.44

1.2

112.00

94.77

u/l

0.58

399

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

197

1245

1.25

2.44

1.2

82.60

84.51

u/l

0.12

175

1093

COPD-related respiratory insufficiency

249

1.65

2.42

1.1

1.2

121.63

91.59

u/l

0.64

216

Umbilical hernia

573

1.42

2.39

1.3

1.2

120.81

93.54

u/l

1.11

489

ILD-related respiratory insufficiency

2.52

2.36

1.0

1.2

107.62

99.22

u/l

0.14

Polyarthrosis

486

1.44

2.36

1.2

91.33

89.41

u/l

0.05

426

Adhesive capsulitis of shoulder

410

1.49

2.35

1.1

1.2

83.05

87.40

u/l

0.17

352

Bacterial, viral and other infectious agents

147

1.84

2.32

1.1

1.2

83.14

90.46

u/l

0.20

129

Ovarian cyst

134

589

1.31

2.29

1.3

1.2

84.38

87.18

u/l

0.16

120

514

Benign neoplasm of eye and adnexa

215

1.68

2.28

1.2

83.68

86.69

u/l

0.05

190

Other noninfective disorders of lymphatic vessels and lymph nodes

2.24

2.28

1.5

1.2

68.00

75.63

u/l

0.15

Granulomatous disorders of skin and subcutaneous tissue

2.57

2.27

1.6

1.1

121.25

75.93

u/l

0.59

Suicide or other Intentional self-harm

554

1.41

2.26

1.2

110.31

84.64

u/l

0.89

484

Periapical abscess

149

1169

1.28

2.23

1.3

1.2

79.64

90.62

u/l

0.86

130

1007

Dermatitis due to substances taken internally

2.10

2.22

1.2

120.11

79.75

u/l

1.03

Disease of hard tissues of teeth, NOS

176

729

1.26

2.22

1.2

80.61

90.25

u/l

0.83

148

636

Other disorders of nervous system

135

1.86

2.22

1.5

1.2

72.75

83.50

u/l

0.42

117

Ganglion

498

1.43

2.22

1.2

76.68

89.31

u/l

0.89

436

Colon adenocarcinoma

202

1.69

2.20

1.1

1.2

132.30

82.67

u/l

0.89

174

Diplopia

256

1.61

2.20

1.4

1.2

91.86

84.72

u/l

0.17

221

Atrophic disorders of skin

368

1.50

2.19

1.2

110.48

78.88

u/l

0.51

321

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

560

1.40

2.18

1.1

1.2

139.20

83.24

u/l

0.49

492

Other congenital malformations of skin

151

1.79

2.15

1.2

1.1

81.95

85.57

u/l

0.12

134

Status post-ami

412

1.41

2.13

1.2

1.3

123.19

94.39

u/l

0.97

356

Other neurotic disorders

2.06

2.11

1.6

1.2

75.62

81.01

u/l

0.22

Other symptoms and signs involving the circulatory and respiratory systems

2.01

2.10

1.3

1.2

80.68

90.02

u/l

0.24

Dementia

834

0.74

2.10

1.2

103.23

93.79

u/l

0.25

721

Other extrapyramidal and movement disorders in other diseases

589

1.38

2.08

1.2

69.46

86.25

u/l

1.32

506

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

640

1.36

2.08

1.2

106.71

82.66

u/l

0.93

560

General examination and investigation of persons without complaint and reported diagnosis

170

707

1.26

2.06

1.2

104.97

86.09

u/l

0.73

150

614

Occupational exposure to risk-factors

0.00

2.05

0.0

1.2

—

89.08

—

Other disorders of the genitourinary system

325

1.51

2.05

1.3

1.2

67.53

84.82

u/l

1.30

287

Respiratory insufficiency

110

1.91

2.03

1.2

164.43

83.08

u/l

0.68

142

1028

1.27

2.03

1.2

96.66

91.52

u/l

0.27

122

885

Autism spe, excluding more controls

3.09

2.01

1.6

1.1

72.50

74.29

u/l

—

Plantar fascial fibromatosis

224

1.61

1.99

1.2

84.23

77.42

u/l

0.18

203

Seborrhoeic keratosis

527

1.39

1.98

1.4

1.2

84.51

79.84

u/l

0.14

448

Meniscus derangement

171

929

1.24

1.96

1.2

1.3

78.12

99.34

u/l

3.05

146

811

COPD, hospital admissions 1, only main diagnosis

109

715

1.31

1.96

1.2

1.3

102.28

97.79

u/l

0.17

615

Transient ischemic attack

179

1179

1.23

1.95

1.2

99.07

87.42

u/l

0.60

156

1028

Dementia, including avohilmo

892

0.76

1.93

1.2

96.35

92.98

u/l

0.08

775

Maternal care for known or suspected malpresentation of fetus

253

0.54

1.92

1.4

1.2

68.47

79.93

u/l

0.36

226

False labour

441

0.68

1.91

1.2

67.36

83.60

u/l

2.16

396

Pneumococcal septicemia

2.25

1.91

1.6

1.2

102.54

76.77

u/l

0.31

Non-Hodgkin lymphoma, all

2.25

1.91

1.5

1.1

152.38

94.39

u/l

0.59

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

331

1.48

1.90

1.2

90.46

86.61

u/l

0.16

289

Spirochaetal infections, other/unspecified

173

1.68

1.89

1.2

1.1

89.71

83.79

u/l

0.11

153

Wide developmental disorders, excluding more controls

2.69

1.89

1.6

1.1

71.89

200.43

u/l

—

657

1.31

1.87

1.3

1.2

101.15

90.00

u/l

0.53

575

Injury of eye and orbit

260

1.54

1.86

1.3

1.2

94.81

83.50

u/l

0.30

226

Epilepsy

738

1.31

1.85

1.2

1.3

117.34

94.41

u/l

0.79

644

Foreign body in alimentary tract

1.94

1.85

1.3

1.1

98.17

102.33

u/l

0.07

Migraine with aura

551

1.36

1.84

1.3

1.2

76.75

83.16

u/l

0.41

488

Atopic dermatitis, strict definition with reimbursement

608

1.34

1.81

1.2

88.86

84.71

u/l

0.12

539

Toxic effect of ethanol

2.27

1.80

1.0

1.2

97.67

88.19

u/l

—

Benign neoplasm: Small intestine

1.97

1.80

1.2

74.47

79.58

u/l

0.22

Autism spe

2.77

1.79

1.6

1.1

72.50

69.04

u/l

—

Graves disease, strict definition

215

1.59

1.79

1.1

72.21

78.93

u/l

0.17

191

Artrosis, including avohilmo

284

1326

1.17

1.79

1.2

88.20

97.92

u/l

0.84

243

1164

Nummular dermatitis

146

1.72

1.77

1.7

1.2

112.63

84.31

u/l

0.42

124

Cervicalgia

496

1.37

1.76

1.3

1.2

66.71

86.34

u/l

2.15

420

Dental pulpitis, including avohilmo

295

1644

1.17

1.76

1.2

1.3

83.96

88.11

u/l

0.35

248

1456

Excessive attrition of teeth

171

1407

1.22

1.75

1.3

82.35

87.99

u/l

0.31

152

1225

Other hammer toe(s) (acquired)

403

1.40

1.75

1.1

1.2

88.46

84.63

u/l

0.19

349

Pure hyperglyceridaemia

2.52

1.74

1.2

1.1

69.00

84.35

u/l

—

Internal derangement of knee

103

797

1.29

1.73

1.2

1.3

89.07

96.15

u/l

0.37

692

Colorectal cancer

445

1.39

1.73

1.1

1.2

182.53

90.87

u/l

0.74

384

Maternal care related to the fetus and amniotic cavity and possible delivery problems

749

0.77

1.72

1.3

1.2

75.30

82.52

u/l

0.38

675

Attention to artificial openings

2.14

1.71

1.6

1.2

129.92

101.33

u/l

0.35

Other and unspecified disorders of vitreous body

150

1205

1.23

1.70

1.3

1.2

69.50

85.95

u/l

2.77

132

1047

Benign neoplasm of urinary organs

1.92

1.70

1.4

1.1

105.18

80.11

u/l

0.81

Undefined dementia

198

0.46

1.67

1.1

90.90

105.99

u/l

—

168

LSIL lesion of the cervix uteri, vagina or vulva

292

1.48

1.66

1.2

79.61

77.76

u/l

0.06

260

Autism

2.59

1.66

1.6

1.2

72.50

71.72

u/l

—

Familial hypercholesterolemia

284

1.48

1.66

1.1

1.2

98.30

90.54

u/l

0.22

235

Chronic laryngitis and laryngotracheitis

342

1.44

1.65

1.2

76.30

86.65

u/l

0.63

293

Haemorrhoids and perianal venous thrombosis

735

1.29

1.65

1.2

81.41

86.69

u/l

0.33

636

Conductive and sensorineural hearing loss

210

1677

0.84

1.65

1.3

1.2

85.33

94.05

u/l

0.66

192

1460

Benign neoplasm: Duodenum

2.26

1.64

1.3

1.1

75.55

79.33

u/l

0.13

Other and unspecified nerve root and plexus disorders, also in other diseases

487

0.66

1.61

1.2

80.63

88.01

u/l

0.17

418

Unspecified event, undetermined intent

2.51

1.60

1.0

1.3

78.13

77.26

u/l

—

Intracerebral haemorrhage

254

1.50

1.59

1.3

1.2

137.52

88.87

u/l

0.56

222

Unspecified dementia

189

0.47

1.59

1.1

90.90

101.21

u/l

—

162

Melanoma in situ of trunk

2.71

1.58

1.0

1.2

120.57

77.62

u/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

362

1.41

1.58

1.1

1.2

85.52

77.15

u/l

0.27

324

Coxibs

358

1.31

1.58

1.1

1.2

74.98

99.98

u/l

1.88

328

Missing teeth due to accident, extraction or parodontitis

205

1635

1.18

1.57

1.2

88.12

90.20

u/l

0.13

174

1423

Other inflammation of vagina/vulva

2.28

1.55

1.2

1.1

112.90

78.31

u/l

—

Other and unspecified effects of external causes

630

1.30

1.55

1.3

1.2

76.09

85.64

u/l

0.69

552

Other and unspecified rosacea

185

1.57

1.51

1.2

74.29

79.54

u/l

0.21

162

Acute epiglottitis

2.88

1.51

1.2

118.67

64.25

u/l

—

Contact with sharp glass

2.16

1.50

1.2

62.55

81.28

u/l

0.59

Skin changes due to chronic exposure to nonionizing radiation

130

977

1.23

1.50

1.2

97.32

91.54

u/l

0.29

111

842

Foreign body entering into or through eye or natural orifice

139

1.66

1.48

1.8

1.1

73.00

96.47

u/l

0.89

120

Oxicams

317

1.33

1.47

1.1

1.2

81.41

106.32

u/l

1.66

287

Other disorders of breast

317

1.42

1.47

1.3

1.2

80.36

79.75

u/l

0.01

287

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

109

1.75

1.46

1.1

1.2

100.36

100.99

u/l

0.01

Actinic keratosis

126

951

1.23

1.46

1.2

98.92

92.16

u/l

0.34

107

816

Superficial injury of ankle and foot

227

1.50

1.46

1.4

1.2

68.93

85.71

u/l

1.28

199

Unspecified mental disorder

125

1020

1.23

1.45

1.1

1.3

79.04

86.67

u/l

0.62

112

889

Alzheimer disease

578

0.75

1.43

1.1

1.2

96.79

96.38

u/l

0.01

502

Benign neoplasm: Kidney

1.98

1.43

1.3

1.1

109.54

71.78

u/l

1.21

Impetigo

1.98

1.43

1.5

1.1

108.08

86.95

u/l

0.27

Otitis externa, unspecified

212

1.51

1.43

1.3

1.1

103.44

83.31

u/l

0.40

186

Wide developmental disorders

2.25

1.40

1.6

1.1

71.89

77.68

u/l

—

Other abnormal products of conception

498

0.74

1.39

1.3

1.2

71.29

78.78

u/l

0.34

446

Non-small cell lung cancer, squamous

2.08

1.38

1.2

1.1

125.55

100.66

u/l

0.21

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.95

1.38

1.3

1.1

120.85

71.30

u/l

1.11

Alzheimer disease, including avohilmo

672

0.77

1.38

1.1

1.2

87.58

95.06

u/l

0.27

582

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

2.62

1.37

1.3

1.1

91.33

82.89

u/l

—

Striking against or struck by other objects

704

1.26

1.37

1.3

104.33

88.66

u/l

0.40

612

Early syphilis

2.96

1.36

1.0

1.2

192.00

81.33

u/l

—

Medial epicondylitis

1.87

1.34

1.1

86.11

83.61

u/l

—

Acute nephritic syndrome

2.16

1.34

1.2

1.1

85.22

72.59

u/l

—

Suppurative otitis media, unspecified

0.00

1.34

0.0

1.2

—

75.33

—

Emotional disorders starting during childhood or adolecense, excluding more controls

2.14

1.33

1.2

47.89

80.92

u/l

—

Certain zoonotic bacterial diseases

2.05

1.33

1.2

1.1

156.64

83.98

u/l

0.56

Burn and corrosion of wrist and hand

2.04

1.33

1.1

60.91

72.67

u/l

0.57

Emotional disorders and disorders of social functioning with onset specific to childhood

2.04

1.33

1.4

1.2

46.91

75.15

u/l

1.17

Acute suppurative otitis media

430

1.32

1.4

1.2

76.34

81.73

u/l

0.21

376

Other problems related to primary support group, including family circumstances

179

1.52

1.31

1.1

1.2

287.41

78.12

u/l

0.66

156

Other and unspecified nonorganic psychotic disorders

386

1.35

1.29

1.1

1.2

75.49

85.54

u/l

0.49

340

Other and unspecified injuries of ankle and foot

1.94

1.27

1.2

1.1

79.42

73.07

u/l

0.07

Open wound of wrist and hand

123

995

1.21

1.27

1.2

1.3

102.18

91.02

u/l

0.38

106

870

Hidradenitis suppurativa

2.01

1.27

1.5

1.1

126.00

77.27

u/l

0.38

470

1.30

1.26

1.2

106.87

90.32

u/l

0.61

409

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

2.41

1.24

1.0

1.1

383.67

84.20

u/l

—

Other and unspecified epidermal thickening

2.01

1.23

1.4

1.2

97.22

79.38

u/l

—

Persons encountering health services in other circumstances

107

873

1.22

1.23

1.4

1.2

109.69

83.23

u/l

1.60

751

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

322

1.30

1.23

1.3

1.2

70.98

81.67

u/l

0.53

286

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

160

1324

1.17

1.22

1.2

72.90

95.48

u/l

3.98

144

1151

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

664

1.25

1.20

1.3

1.2

90.29

87.12

u/l

0.12

588

Other disorders of amniotic fluid and membranes

257

0.61

1.19

1.1

1.2

102.88

80.19

u/l

0.44

228

Use of other anti-dementia drugs

539

0.75

1.19

1.1

1.2

95.42

96.91

u/l

0.03

465

Use of memantine

539

0.75

1.19

1.1

1.2

95.42

96.91

u/l

0.03

465

Other and unspecified nail disorders

2.12

1.18

1.5

1.1

81.88

77.12

u/l

—

Suggestive for eosinophilic asthma

189

1.48

1.18

1.1

94.14

82.36

u/l

0.27

161

LSIL lesion of the cervix uteri

206

1.46

1.17

1.1

1.2

79.44

76.39

u/l

0.10

183

Hyperplasia of prostate

436

1.24

1.17

1.3

123.16

108.95

u/l

0.33

375

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

126

0.47

1.16

1.5

1.2

45.33

86.89

u/l

—

116

Hallux valgus (acquired)

107

633

1.22

1.16

1.2

74.00

86.69

u/l

1.43

100

552

Other and unspecified hydrocephalus

0.00

1.16

0.0

1.2

—

69.69

—

Deficiency of other B group vitamins

2.06

1.15

1.3

1.2

55.63

74.41

u/l

—

Early syphilis

2.51

1.15

1.0

1.2

192.00

76.00

u/l

—

Strabismus

604

1.26

1.15

1.3

1.2

126.29

85.83

u/l

1.00

528

Focal brain injury

110

1.64

1.15

1.1

1.3

104.54

87.09

u/l

0.22

Paracetamol or NSAID medication

148

1.40

1.14

1.1

1.2

67.22

98.98

u/l

1.22

132

Cervical disc disorders

109

904

1.21

1.14

1.2

1.3

75.09

93.33

u/l

1.90

776

Excessive, frequent and irregular menstruation

130

597

1.19

1.12

1.2

85.83

86.91

u/l

0.05

117

519

Medical abortion

220

1044

1.14

1.11

1.2

90.15

80.11

u/l

0.71

194

921

Car occupant injured in other and unspecified transport accidents

388

1.32

1.11

1.2

85.05

89.15

u/l

0.13

342

Toxic effects of substances chiefly nonmedicinal as to source

201

1.45

1.09

1.1

1.2

70.14

95.75

u/l

1.18

172

Kela-code for severe mental illness

107

891

1.20

1.09

1.1

1.2

80.79

87.71

u/l

0.47

776

Benign neoplasm: Other and unspecified parts of small intestine

2.20

1.08

1.0

1.2

68.29

79.04

u/l

—

Presence of other functional implants

184

1111

1.15

1.05

1.3

1.2

106.02

84.89

u/l

1.51

168

952

Other fall from one level to another

453

1.28

1.05

1.4

1.2

77.88

87.78

u/l

0.59

390

Wet age-related macular degeneration

380

1.30

1.04

1.3

1.2

97.00

90.04

u/l

0.24

326

Inflammatory diseases of female pelvic organs

205

1324

1.14

1.04

1.3

1.2

80.75

81.40

u/l

0.04

180

1178

Migraine

149

1039

1.16

1.03

1.3

78.34

87.30

u/l

0.93

131

917

Atopic dermatitis, strict definition

621

1.23

1.02

1.2

82.47

81.50

u/l

0.03

553

Other predominantly sexually transmitted diseases, not elsewhere classified

333

1.32

1.01

1.2

97.08

83.11

u/l

0.26

292

Fistulae involving female genital tract

2.01

1.00

1.1

1.2

49.86

55.41

u/l

—

Obstructed labour due to malposition and malpresentation of fetus

483

0.75

1.00

1.2

71.15

88.06

u/l

0.78

432

Diseases of inner ear

178

1508

1.14

0.99

1.2

81.73

89.45

u/l

0.49

157

1307

Malignant cancer of tonsil and base of tongue

2.18

0.98

1.0

1.2

107.60

75.28

u/l

—

Rosacea

249

1.37

0.97

1.2

1.1

82.69

83.43

u/l

0.02

220

Diseases of male genital organs

132

568

1.17

0.96

1.3

111.72

104.62

u/l

0.20

110

494

Injury of muscle and tendon at hip and thigh level

182

1.43

0.95

1.1

1.2

59.33

87.83

u/l

2.21

158

Alzheimer’s disease (Late onset)

451

0.76

0.94

1.1

1.2

99.93

96.16

u/l

0.07

391

Effects of foreign body entering through natural orifice

506

1.25

0.94

1.2

1.3

81.31

89.44

u/l

0.30

434

Other and unspecified tonsillitis

515

1.22

0.94

1.2

90.10

83.23

u/l

0.29

444

Leiomyoma of uterus

225

1134

1.13

0.94

1.3

1.2

78.69

83.55

u/l

0.41

199

1002

Disorders of ocular muscles, binocular movement, accommodation and refraction

135

1156

1.16

0.93

1.3

1.2

88.41

86.65

u/l

0.07

121

1001

Other bullous disorders

1.83

0.92

1.1

100.40

73.10

u/l

—

Abnormal involuntary movements

295

1.32

0.92

1.3

1.2

85.77

84.31

u/l

0.03

255

Use of antiglaucoma preparations and miotics

167

1.44

0.92

1.2

105.63

80.48

u/l

0.72

142

Other obstetric conditions, not elsewhere classified

338

1.24

0.91

1.3

1.2

69.81

82.40

u/l

0.67

302

Anorexia (incl.atypical)

1.63

0.90

1.4

1.2

67.71

83.85

u/l

0.37

Astigmatism

102

1.57

0.90

1.4

1.1

143.50

86.41

u/l

0.30

Myocardial infarction, unclassifiable

422

1.25

0.89

1.3

1.2

119.91

101.02

u/l

0.44

357

Open wound of shoulder and upper arm

2.08

0.89

1.0

1.2

102.67

95.79

u/l

—

Major anomalies of jaw size

1.87

0.87

1.0

1.2

64.63

66.59

u/l

—

Dissociative [conversion] disorders

1.86

0.87

1.3

1.2

69.38

84.30

u/l

—

Any dementia

726

0.84

0.86

1.2

109.23

92.83

u/l

0.48

629

Migraine without aura

432

1.25

0.85

1.1

1.2

77.17

81.71

u/l

0.21

387

Deviated nasal septum

780

1.18

0.82

1.4

1.2

79.50

95.30

u/l

0.93

678

Degenerative diseases of the nervous system

657

0.84

0.79

1.2

93.31

94.70

u/l

0.04

568

Other strabismus

481

1.22

0.78

1.4

1.2

123.19

84.44

u/l

0.71

422

Female genital prolapse

543

0.84

0.78

1.1

1.2

64.00

86.78

u/l

2.95

468

Alzheimer’s disease, strict definition

492

0.80

0.78

1.1

1.2

91.68

94.61

u/l

0.06

429

Other disorders of pigmentation

1.59

0.78

1.2

1.1

116.38

75.58

u/l

0.35

Alcohol abuse, main dg, excluding more controls

278

1.30

0.77

1.1

1.3

112.97

89.13

u/l

0.45

239

Other specific arthropathies, wide

1.77

0.76

1.2

1.1

81.67

70.52

u/l

—

Acute appendicitis, no complications

160

1417

1.12

0.76

1.2

1.3

97.86

89.64

u/l

0.42

146

1229

Tonsillectomy and adenotomy

118

941

0.87

0.75

1.3

1.2

77.79

85.89

u/l

0.53

104

843

Disorders of vestibular function (Vertigo)

152

1327

1.13

0.75

1.2

85.98

87.34

u/l

0.06

133

1145

Emotional disorders starting during childhood or adolescence

1.69

0.75

1.2

47.89

96.53

u/l

—

Cerebral aneurysm, nonruptured

192

1.36

0.75

1.2

1.1

78.79

77.57

u/l

0.05

173

Retinal breaks without detachment

378

1.25

0.74

1.3

1.2

88.13

86.08

u/l

0.06

334

Diseases of the ear and mastoid process

385

1791

1.08

0.73

1.3

1.2

83.73

92.67

u/l

1.01

339

1572

Psoriasis (vulgaris), strict definition

1.64

0.73

1.1

91.22

89.45

u/l

—

Long labour

478

0.80

0.73

1.4

1.2

80.10

83.80

u/l

0.15

426

Herpesviral [herpes simplex] infections

597

1.19

0.73

1.2

84.40

84.34

u/l

0.00

527

Benign paroxysmal vertigo

810

1.16

0.72

1.2

79.25

83.04

u/l

0.15

704

Allergic contact dermatitis due to drugs in contact with skin

1.80

0.72

1.3

1.1

98.43

88.24

u/l

—

Chronic iridocyclitis

1.53

0.72

1.1

1.2

87.07

83.79

u/l

0.05

Lesion of ulnar nerve

317

1.26

0.71

1.2

79.45

87.94

u/l

0.43

271

Juvenile osteochondrosis

1.75

0.71

1.4

1.1

48.29

70.20

u/l

—

Other spirochaetal diseases

821

1.16

0.71

1.2

76.33

85.54

u/l

0.62

713

Type of accident

718

0.83

0.70

1.3

1.2

146.88

86.54

u/l

1.11

623

Glucosamine medication

134

1204

0.89

0.69

1.2

78.65

90.59

u/l

1.24

108

1049

Extrapyramidal and movement disorders

116

1020

1.14

0.69

1.2

76.98

90.80

u/l

1.20

882

Suppurative and unspecified otitis media

655

1.16

0.68

1.4

1.2

80.26

81.75

u/l

0.06

572

Iridocyclitis in diseases classified elsewhere

1.86

0.68

1.2

1.1

106.60

72.76

u/l

—

Colorectal adenocarcinoma

373

1.23

0.67

1.2

117.55

91.43

u/l

0.57

319

Carcinoma in situ of breast, other/unspecified

1.79

0.66

1.4

1.1

46.40

77.78

u/l

—

Gestational diabetes (for exclusion)

528

1.16

0.66

1.3

1.2

77.54

82.28

u/l

0.31

471

Desensitization to allergens

1.57

0.65

1.3

1.2

81.73

86.56

u/l

0.07

Lyme disease

819

1.15

0.65

1.2

74.26

85.57

u/l

0.85

712

Spirochaetal infections, other/unspecified

820

1.15

0.64

1.2

74.26

85.57

u/l

0.85

712

Other predominantly sexually transmitted diseases, not elsewhere classified

395

1.22

0.64

1.2

103.37

81.30

u/l

0.48

350

Other spirochaetal diseases

830

1.15

0.63

1.2

76.33

85.50

u/l

0.61

721

Crowding of teeth, including avohilmo

1.42

0.63

1.3

1.2

79.41

87.79

u/l

0.11

Superficial injury of forearm

164

1.34

0.62

1.2

78.60

87.89

u/l

0.25

141

Glaucoma

184

1440

1.10

0.62

1.3

1.2

94.56

88.80

u/l

0.30

157

1249

Disorders of eyelid in diseases classified elsewhere

1.59

0.62

1.0

1.2

59.30

75.59

u/l

—

Cluster headache, strict

1.59

0.62

1.5

1.1

71.20

83.38

u/l

—

Malignant cancer of tonsil and base of tongue, including Hilmo

1.67

0.61

1.0

1.1

107.60

73.40

u/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

637

1.16

0.60

1.2

83.95

82.18

u/l

0.06

567

Infective dermatitis

218

1.29

0.60

1.1

77.47

89.11

u/l

0.41

188

Vasomotor and allergic rhinitis

104

903

1.13

0.59

1.3

1.2

81.08

94.25

u/l

0.76

789

Abrasion of teeth

105

930

1.13

0.59

1.2

78.69

85.33

u/l

0.30

812

Contact with and exposure to communicable diseases

604

0.84

0.59

1.3

1.2

104.30

87.63

u/l

0.28

536

Focal epilepsy

473

1.18

0.58

1.1

1.2

121.38

86.93

u/l

0.90

408

Oligomenorrhoea

1.48

0.57

1.3

1.2

93.75

75.06

u/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

766

0.86

0.57

1.2

139.77

85.93

u/l

1.07

662

Cervicobrachial syndrome

539

1.17

0.57

1.1

1.2

78.74

89.34

u/l

0.58

466

Inguinal hernia, bilateral

207

0.72

0.56

2.0

1.2

90.07

94.48

u/l

0.09

171

Use of galantamine

149

0.67

0.56

1.2

81.80

96.82

u/l

—

126

Pollen allergy

351

1.21

0.56

1.3

1.2

90.03

84.43

u/l

0.14

310

Primary coxarthrosis, bilateral

775

0.86

0.56

1.2

80.16

90.72

u/l

0.62

660

Irregular menses

143

1021

1.11

0.55

1.2

77.64

80.99

u/l

0.23

131

903

Diseases of middle ear and mastoid

152

1128

1.10

0.55

1.3

1.2

80.74

87.38

u/l

0.44

140

974

Acetic acid derivatives and related substances

351

1.15

0.55

1.1

1.2

103.82

101.50

u/l

0.05

321

Anti-inflammatory and antirheumatic products, non-steroids

373

1.15

0.55

1.1

1.2

100.00

97.86

u/l

0.04

342

Postmenopausal atrophic vaginitis

106

519

1.13

0.54

1.2

71.17

86.24

u/l

1.12

448

Benign neoplasm: Conjunctiva

1.50

0.54

1.2

77.67

78.66

u/l

—

Diseases of appendix

219

1825

1.08

0.54

1.2

99.62

90.36

u/l

0.63

204

1593

Coxarthrosis, primary

195

1519

1.09

0.54

1.2

84.60

90.92

u/l

0.47

172

1320

Primary gonarthrosis, bilateral

172

1348

1.09

0.53

1.2

86.65

90.68

u/l

0.19

148

1177

therapeutic use

1.48

0.53

1.4

1.1

124.56

79.57

u/l

—

Unspecified abortion

125

1.36

0.53

1.2

1.1

96.47

71.20

u/l

0.50

112

Additional codes for the location of defect, injury or illness

108

1.39

0.53

1.3

1.2

57.87

81.67

u/l

1.48

Tooth agenesis EXCLUDE clefts and syndromes

1.54

0.53

1.2

296.50

87.84

u/l

—

Prolapse and hernia of ovary and fallopian tube

0.62

0.52

1.3

1.2

66.00

85.38

u/l

—

Appendicitis, broad definition

217

1818

1.08

0.52

1.2

100.11

90.52

u/l

0.65

202

1587

Outcome of delivery

221

1.20

0.51

1.1

1.3

68.78

88.83

u/l

1.77

198

Gonarthrosis,primary

298

1718

1.07

0.51

1.2

86.72

93.87

u/l

0.61

257

1509

Any dementia, excluding more controls

647

0.88

0.51

1.2

106.39

92.22

u/l

0.37

566

Achilles tendinitis

233

1.25

0.50

1.2

106.65

83.87

u/l

0.46

198

Female infertility, cervical, vaginal, other or unspecified origin

457

1.14

0.50

1.2

1.3

77.81

89.37

u/l

0.72

404

Chronic mastoiditis

1.47

0.50

1.0

1.2

112.67

74.58

u/l

—

Excessive earwax

140

1497

0.91

0.50

1.1

1.2

83.27

92.82

u/l

0.67

125

1305

Acute appendicitis

202

1749

1.08

0.49

1.2

102.53

90.88

u/l

0.78

187

1529

Nasal polyp

445

1.17

0.49

1.2

101.85

91.00

u/l

0.35

377

Alopecia areata

1.56

0.49

1.1

100.71

84.10

u/l

—

Female infertility

468

1.13

0.48

1.2

1.3

76.44

89.32

u/l

0.90

412

Polyp of the female genital tract

108

557

1.11

0.48

1.2

69.80

89.18

u/l

1.92

482

Benign lipomatous neoplasm

784

0.88

0.47

1.1

1.2

68.88

87.40

u/l

1.56

670

Combinations of oral blood glucose lowering drugs

691

1.13

0.47

1.2

1.3

107.99

84.13

u/l

0.92

589

Other obstetric trauma

1.41

0.47

1.2

87.50

84.47

u/l

0.03

Parkinson's disease, including avohilmo

343

0.82

0.46

1.4

1.2

93.14

89.63

u/l

0.09

294

Noninflammatory disorders of female genital tract

109

606

0.90

0.46

1.1

1.2

79.33

85.93

u/l

0.39

528

Chronic diseases of tonsils and adenoids

211

1432

0.93

0.46

1.3

1.2

70.00

93.31

u/l

4.44

187

1255

Injuries to the neck

486

1.15

0.45

1.3

1.2

83.93

88.79

u/l

0.15

420

Inguinal or femoral hernia, bilateral

209

0.76

0.45

2.0

1.2

90.19

94.07

u/l

0.09

173

Other acquired deformities of musculoskeletal system and connective tissue

1.40

0.44

1.2

1.1

110.42

80.58

u/l

0.67

Other specified/unspecified soft tissue disorders

1.40

0.44

1.2

94.58

77.16

u/l

0.31

Cluster headache, wide

1.45

0.44

1.5

1.1

71.20

81.56

u/l

—

Salpingitis and oophoritis

507

1.15

0.43

1.5

1.2

80.11

79.08

u/l

0.04

448

Non-small cell lung cancer, squamous, helper endpoint

1.41

0.43

1.2

1.1

125.55

114.07

u/l

0.08

Alcohol abuse, main dg

303

1.19

0.43

1.1

1.2

112.97

94.03

u/l

0.33

254

Schizophrenia or delusion, excluding more controls

662

1.12

0.42

1.1

1.2

72.55

83.05

u/l

0.79

585

Other hearing loss

738

1.11

0.42

1.1

1.2

86.22

99.30

u/l

0.68

632

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

679

0.88

0.41

1.3

1.2

90.67

89.33

u/l

0.04

586

All dysplastic lesions of the cervix uteri

535

1.13

0.40

1.2

83.94

81.51

u/l

0.08

478

Alzheimer’s disease (Late onset), excluding more controls

221

0.83

0.40

1.1

1.2

88.55

103.88

u/l

0.23

195

Persons encountering health services in circumstances related to reproduction

170

1065

1.08

0.39

1.3

1.2

82.15

94.23

u/l

0.75

150

944

Torsion of ovary, ovarian pedicle and fallopian tube

1.39

0.38

1.0

1.1

71.80

66.90

u/l

—

Tinnitus

647

1.11

0.37

1.2

77.25

88.86

u/l

0.68

554

Other noninflammatory disorders of vulva and perineum

234

1.20

0.37

1.2

73.43

85.09

u/l

0.49

203

Drug-induced adrenocortical insufficiency

1.35

0.37

1.2

103.80

91.94

u/l

—

Postmenopausal bleeding

106

517

1.09

0.37

1.2

78.01

86.22

u/l

0.56

446

Other degenerative diseases of the nervous system

519

1.11

0.36

1.2

89.72

90.40

u/l

0.02

455

Cluster headache, strict, including avohilmo

1.36

0.36

1.5

1.1

71.73

81.07

u/l

0.26

Congenital malformations of the circulatory system

273

1.17

0.35

1.5

1.1

129.79

104.93

u/l

0.21

234

Secondary polycythaemia

1.40

0.35

1.0

1.2

60.83

71.89

u/l

—

Menorrhagia

112

572

1.09

0.34

1.2

89.30

88.72

u/l

0.02

104

497

Other melanin hyperpigmentation

1.37

0.34

1.3

1.2

52.17

85.38

u/l

—

Manic episode

1.37

0.34

1.3

1.2

88.50

78.47

u/l

—

Lichen planus, including avohilmo

490

1.12

0.34

1.3

1.2

100.22

86.87

u/l

0.48

424

Parkinson's disease

328

0.85

0.32

1.4

1.2

93.14

90.90

u/l

0.05

282

Presbycusis

319

1.15

0.32

1.1

1.2

77.72

100.42

u/l

1.28

270

Parkinson's disease, strict definition

306

0.85

0.32

1.4

1.2

90.19

92.58

u/l

0.06

262

Scleritis and episcleritis

119

1.26

0.31

1.4

1.1

88.07

74.57

u/l

0.28

101

Pregnancy hypertension

115

958

1.08

0.31

1.2

69.44

83.40

u/l

1.78

108

851

Anisometropia and aniseikonia

1.30

0.30

1.3

1.1

238.43

71.24

u/l

—

Blepharochalasis

860

0.92

0.30

1.3

1.2

79.12

82.62

u/l

0.14

748

Other disorders of prostate

1.25

0.29

1.6

1.1

90.14

94.24

u/l

—

Acute alcohol intoxication

544

1.10

0.29

1.1

1.3

101.90

98.15

u/l

0.06

468

Viral meningitis

1.23

0.29

1.3

1.2

66.86

85.58

u/l

—

Glaucoma-related operations

121

1.24

0.28

1.1

1.2

157.00

81.57

u/l

—

106

Impingement syndrome of shoulder

593

1.10

0.28

1.1

1.3

93.56

90.90

u/l

0.07

523

Congenital malformations of heart and great arteries

234

1.16

0.28

1.5

1.1

135.22

105.07

u/l

0.21

202

Nontraumatic intracranial haemmorrhage

451

1.11

0.27

1.3

1.2

128.70

88.75

u/l

0.62

394

Nontoxic goitre/thyroid nodule

866

1.07

0.26

1.2

61.70

83.61

u/l

4.46

753

Other benign neoplasms of skin

109

1021

1.07

0.26

1.3

1.2

91.69

86.88

u/l

0.16

883

Use of ropinirole

0.70

0.26

1.6

1.1

74.60

81.65

u/l

—

Obstructed labour due to maternal pelvic abnormality

457

0.90

0.26

1.4

1.2

69.66

82.08

u/l

0.70

408

Traumatic amputation of wrist and hand

0.67

0.26

1.4

1.2

119.80

95.90

u/l

—

Other noninflammatory disorders of uterus, except cervix

505

1.08

0.25

1.2

73.93

84.89

u/l

0.90

434

Other sexually transmitted chlamydial diseases

1.23

0.25

1.1

1.3

70.67

104.62

u/l

—

Hydrocele

217

1.15

0.24

1.1

1.3

100.11

102.86

u/l

0.04

180

Polycystic ovarian syndrome, consortium definition

230

1306

1.04

0.24

1.2

79.61

81.88

u/l

0.16

214

1147

Complications predominantly related to the puerperium

641

0.92

0.23

1.3

1.2

72.46

79.99

u/l

0.45

572

Normotensive glaucoma

199

1.16

0.23

1.2

104.35

83.44

u/l

0.35

178

Respiratory conditions due to other external agents

1.32

0.23

1.6

1.2

81.20

75.82

u/l

—

Keratoconus

1.32

0.23

1.2

174.20

73.65

u/l

—

Adenocarcinoma of pancreas

1.32

0.23

1.4

1.1

246.80

97.77

u/l

—

Diabetes mellitus in pregnancy

421

1.08

0.22

1.3

1.2

85.39

80.31

u/l

0.21

374

Acute alcohol intoxication, ICD10

409

1.10

0.22

1.0

1.2

114.48

95.57

u/l

0.32

348

Allergic rhinitis

700

1.07

0.22

1.2

83.04

85.71

u/l

0.10

619

Migraine without aura and triptan purchases

352

1.11

0.22

1.1

1.2

75.59

79.79

u/l

0.17

313

Polycystic ovarian syndrome, broad definition

146

0.82

0.22

1.2

96.83

75.54

u/l

0.61

126

Other and unspecified degenerative diseases of nervous system

1.22

0.22

1.2

105.60

74.14

u/l

—

Coxarthrosis, primary, with hip surgery

145

1292

1.05

0.22

1.2

82.83

90.98

u/l

0.68

129

1117

Uterine polyps

294

0.88

0.21

1.1

1.2

94.57

83.93

u/l

0.21

253

Other disorders of ear

276

1868

0.97

0.20

1.3

1.2

82.02

93.38

u/l

1.29

246

1633

Hypertrophy of breast

460

1.09

0.20

1.1

1.2

70.65

82.08

u/l

0.84

412

Glaucoma suspect

110

1043

1.05

0.20

1.2

91.85

84.86

u/l

0.29

894

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

1.25

0.20

1.0

1.1

98.17

75.74

u/l

—

Endometriosis of ovary

440

1.09

0.20

1.3

1.2

95.49

90.23

u/l

0.11

379

Other symptoms and signs involving the nervous and musculoskeletal systems

114

1083

1.05

0.19

1.3

1.2

106.74

84.98

u/l

0.62

939

Burn and corrosion of trunk

1.20

0.19

1.2

59.00

73.18

u/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.20

0.19

1.7

1.3

88.67

65.58

u/l

—

Other female pelvic inflammatory diseases

417

0.91

0.19

1.3

1.2

76.91

76.67

u/l

0.01

366

Muscle strain

1.18

0.19

1.5

1.2

47.50

83.62

u/l

—

Cluster headache, wide,, including avohilmo

1.22

0.19

1.5

1.1

71.73

84.76

u/l

0.39

Oral lichen planus

1.13

0.18

1.5

1.1

85.50

72.33

u/l

—

Other intracranial haemorrhages

1.13

0.18

1.7

1.1

171.67

94.56

u/l

—

Disorder of external ear, unspecified

1.21

0.18

1.3

1.1

110.29

74.82

u/l

—

Pathological resorption of teeth

1.17

0.17

1.1

1.2

68.43

74.62

u/l

—

Injury of muscle and tendon at lower leg level

300

1.10

0.17

1.7

1.2

85.39

94.08

u/l

0.20

255

Other diseases of spinal cord

1.15

0.17

1.7

1.1

92.29

84.27

u/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

130

1082

1.04

0.17

1.2

66.52

82.91

u/l

2.69

123

957

Aneurysms, operations, SAH

393

0.92

0.17

1.2

84.64

81.28

u/l

0.17

343

Subacute thyroiditis

1.11

0.17

1.3

1.1

66.43

75.57

u/l

—

Injury of nerves at wrist and hand level

0.76

0.17

1.0

1.2

70.00

76.44

u/l

—

Contact with nonpowered hand tool

0.73

0.17

1.0

1.2

81.60

88.67

u/l

—

Organic, including symptomatic, mental disorders

150

1026

1.04

0.17

1.2

92.55

94.20

u/l

0.06

133

880

Benign neoplasm: Skin of ear and external auricular canal

0.71

0.16

1.8

1.2

51.00

90.43

u/l

—

Maltreatment syndromes

0.71

0.16

1.4

1.1

59.40

91.00

u/l

—

Open bite

1.18

0.16

1.3

1.2

711.38

72.71

u/l

—

Postpartum haemorrhage due to anatomy

120

0.83

0.16

1.4

1.2

52.00

66.51

u/l

—

101

Other menopausal disorders

509

1.05

0.16

1.1

1.2

72.60

87.46

u/l

1.01

439

Failed induction of labour

1.13

0.16

1.0

1.3

56.38

89.98

u/l

—

Other condition

302

1.09

0.16

1.3

1.2

202.39

85.25

u/l

1.26

259

Dysplasia of cervi uteri

436

1.06

0.15

1.2

1.3

77.21

91.92

u/l

0.73

384

Spontaneous abortion

124

871

0.96

0.15

1.2

71.30

78.80

u/l

0.68

115

772

Systemic atrophies primarily affecting the central nervous system

1.10

0.15

1.1

1.2

73.63

85.76

u/l

—

Lichen sclerosus et atrophicus

245

0.90

0.15

1.2

61.82

77.66

u/l

1.26

215

Gonarthrosis, primary, with knee surgery

184

1419

1.03

0.15

1.2

81.57

91.13

u/l

0.82

161

1239

Hypertrophy of breast in women and men

517

1.06

0.15

1.2

70.73

83.12

u/l

1.04

462

Normal-pressure hydrocephalus

0.79

0.14

1.0

1.2

111.71

89.83

u/l

—

Primary open-angle glaucoma

861

0.95

0.14

1.2

93.61

90.14

u/l

0.10

740

Follicular lymphoma, hilmo

1.18

0.14

1.2

83.73

84.73

u/l

0.02

Bicipital tendinitis

0.79

0.14

1.0

1.1

125.43

79.51

u/l

—

Pedal cyclist injured in transport accident

508

1.06

0.14

1.4

1.2

95.72

85.61

u/l

0.35

439

Endometriosis

104

584

1.04

0.14

1.2

87.82

87.73

u/l

0.00

509

Antenatal screening

305

0.94

0.14

1.2

1.3

61.04

87.94

u/l

4.26

278

Use of levodopa decarboxylase inhibitor

295

0.91

0.14

1.4

1.2

81.27

93.12

u/l

0.35

251

Episcleritis

103

1.17

0.13

1.5

1.1

81.83

70.94

u/l

0.22

Maternal care for known or suspected abnormality of pelvic organs

397

0.94

0.13

1.3

1.2

70.84

81.44

u/l

0.52

356

Supervision of high-risk pregnancy

294

1.06

0.13

1.1

1.3

73.11

86.51

u/l

0.67

268

Mandibular retrognathia

100

0.80

0.13

1.0

1.1

93.50

77.98

u/l

—

Glaucoma, exfoliation

232

0.90

0.13

1.1

1.2

114.31

86.78

u/l

0.32

197

Other and unspecified disorders of skin and subcutaneous tissue

117

0.85

0.13

1.0

1.2

67.90

79.08

u/l

—

101

Pedal cyclist injured in noncollision transport accidents

238

1.09

0.13

1.2

111.21

87.15

u/l

0.53

207

Supervision of normal pregnancy

296

0.95

0.11

1.2

1.3

62.39

86.50

u/l

3.56

271

Dentofacial anomalies [including malocclusion]

189

1556

0.98

0.11

1.3

1.2

99.69

87.43

u/l

0.23

170

1374

Benign neoplasm: Skin of eyelid, including canthus

376

1.06

0.11

1.2

66.36

86.54

u/l

2.61

330

Injury of muscle and tendon at shoulder and upper arm level

893

0.96

0.11

1.2

1.3

102.09

90.58

u/l

0.38

763

Later onset COPD

526

1.05

0.11

1.2

102.05

99.80

u/l

0.06

454

Propionic acid derivatives

373

0.96

0.11

1.1

1.2

110.97

97.86

u/l

0.26

342

Temporomandibular joint disorders, including avohilmo

115

1099

1.03

0.10

1.2

72.39

84.15

u/l

1.02

100

967

Gestational [pregnancy-induced] hypertension

565

0.95

0.10

1.1

1.2

58.84

84.17

u/l

4.60

498

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

144

1.11

0.10

1.2

88.25

77.79

u/l

0.17

126

Contraceptive management

107

774

0.97

0.10

1.4

1.2

71.86

91.39

u/l

2.13

686

Acute lymphadenitis

1.15

0.09

1.5

1.1

100.50

88.97

u/l

—

Benign neoplasm: other/unspecified salivary gland

1.09

0.09

1.3

1.2

130.83

73.06

u/l

—

Pre-eclampsia or poor fetal growth

703

1.03

0.08

1.3

1.2

72.55

83.07

u/l

1.01

628

Serous carcinoma of ovary, including Hilmo

0.82

0.08

1.6

1.1

91.80

75.10

u/l

—

Ectopic pregnancy

470

0.96

0.08

1.1

1.2

67.36

75.77

u/l

0.38

413

Inguinal hernia

135

923

0.98

0.08

1.3

1.2

95.90

98.70

u/l

0.10

113

797

Benign neoplasm: Skin, unspecified

1.08

0.07

1.4

1.2

72.75

80.24

u/l

—

Alzheimer’s disease (Early onset), excluding more controls

1.03

0.07

1.1

1.2

58.75

90.37

u/l

—

Triptan medication for migraine, min. 3 purchases

148

1152

0.98

0.07

1.2

78.32

83.65

u/l

0.43

130

1022

Alzheimer’s disease (Early onset)

0.88

0.06

1.1

1.2

58.75

86.09

u/l

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

225

1501

1.01

0.06

1.2

1.3

71.38

88.44

u/l

3.22

198

1329

Triptan medication for migraine, single purchase ok

225

1501

1.01

0.06

1.2

1.3

71.38

88.44

u/l

3.22

198

1329

Unknown and unspecified causes of morbidity

109

1.10

0.06

1.5

1.1

118.42

72.79

u/l

0.58

Lichen ruber planus, wide definition including periferal and oral lichen planus

602

1.03

0.06

1.3

1.2

97.16

85.43

u/l

0.47

521

Other maternal disorders predominantly related to pregnancy

161

1026

0.98

0.06

1.2

79.85

80.11

u/l

0.02

149

909

Benign neoplasm: Cerebral meninges

221

0.95

0.04

1.2

86.47

77.35

u/l

0.34

198

Benign neoplasm of meninges

239

1.05

0.04

1.5

1.2

83.39

79.98

u/l

0.12

214

Other symptoms and signs involving the digestive system and abdomen

398

1.03

0.04

1.3

1.2

119.28

77.21

u/l

0.93

347

Disorders of refraction and accommodation

620

0.98

0.03

1.3

1.2

88.50

84.01

u/l

0.07

547

Other disorders of eyelid

130

1252

0.99

0.03

1.2

85.55

89.77

u/l

0.21

115

1088

Artificial joint operation, meniscal resection

281

1837

0.99

0.03

1.2

84.00

94.26

u/l

1.19

246

1611

Peritonsillar abscess

431

0.97

0.03

1.2

86.49

92.30

u/l

0.16

370

Other benign neoplasms of connective and other soft tissue

201

1.05

0.03

1.4

1.1

74.36

82.12

u/l

0.27

177

Benign leiomyoma with endometriosis

460

0.98

0.02

1.2

92.92

77.98

u/l

0.36

402

Allergic contact dermatitis

303

1.02

0.01

1.1

1.2

109.65

80.24

u/l

1.00

270

Dislocation, sprain and strain of joints and ligaments of knee

151

1399

0.99

0.01

1.3

1.2

82.79

87.16

u/l

0.25

135

1222

Alzheimer disease, excluding more controls

275

0.98

0.01

1.2

84.16

95.62

u/l

0.25

239

Pregnancy with abortive outcome

201

1052

1.00

0.00

1.2

81.36

79.95

u/l

0.08

175

929

Varicose veins

187

1407

1.00

0.00

1.3

1.2

91.04

87.83

u/l

0.18

160

1228

Schizophrenia, schizotypal and delusional disorders

752

1.00

0.00

1.1

1.2

75.11

87.54

u/l

0.88

660

Primary open-angle glaucoma, strict

706

1.00

0.00

1.3

1.2

89.22

89.25

u/l

0.00

603

Parkinson's disease, strict definition, excluding more controls

244

1.01

0.00

1.4

1.3

90.19

95.55

u/l

0.13

212

Female infertility, associated with anovulation

1.05

0.00

1.2

1.3

74.80

80.60

u/l

—

Chronic suppurative otitis media

122

0.98

0.00

1.5

1.1

69.67

86.12

u/l

0.42

108

Parkinson's disease, excluding more controls

259

1.02

0.00

1.4

1.3

93.14

94.34

u/l

0.03

224

Schizophrenia or delusion

755

0.99

0.00

1.1

1.2

72.55

87.50

u/l

1.25

662

Endometriosis ASRM stages 3,4

582

1.00

0.00

1.3

1.2

93.16

78.96

u/l

0.42

512

Nontoxic multinodular goitre

531

1.00

0.00

1.2

59.84

83.44

u/l

3.24

464

Moderate visual impairment, binocular

1.02

0.00

1.2

1.1

40.80

67.24

u/l

—

Other congenital malformations of heart

0.00

0.0

1.1

—

95.75

—

Placental disorders

0.00

0.0

1.1

—

65.88

—

Slow fetal growth and fetal malnutrition

0.00

0.0

1.0

—

88.25

—

Benign neoplasm: Other and unspecified parts of mouth

0.92

-0.00

1.5

1.2

77.17

82.85

u/l

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

1.2

—

76.17

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.0

—

127.80

—

Chondromalacia

0.91

-0.00

1.0

1.1

72.00

80.25

u/l

—

Lateral epicondylitis

330

1.00

-0.00

1.2

62.67

83.04

u/l

1.48

292

Vascular dementia (subcortical)

1.00

-0.00

1.0

1.2

133.00

89.50

u/l

—

Congenital malformations of eye, ear, face and neck

0.91

-0.00

1.1

206.33

82.40

u/l

—

Impacted maxillary canine

0.00

-0.00

0.0

1.0

—

47.14

—

Postprocedural disorders of eye and adnexa, not elsewhere classified

0.00

-0.00

0.0

1.2

—

67.20

—

Congenital malformations of larynx

0.00

-0.00

0.0

1.0

—

49.80

—

Testicular dysfunction

1.02

-0.00

1.2

1.1

52.83

102.57

u/l

—

Birth asphyxia

0.00

-0.00

0.0

1.0

—

25.60

—

Other infections specific to the perinatal period

0.00

-0.00

0.0

1.2

—

25.40

—

Other facial nerve disorders

0.94

-0.00

1.0

1.1

60.40

73.47

u/l

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

-0.00

0.0

1.0

—

103.00

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS